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Sulfide catabolism ameliorates hypoxic brain injury
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The mammalian brain is highly vulnerable to oxygen deprivation, yet the mechanism
underlying the brain’s sensitivity to hypoxia is incompletely understood. Hypoxia induces
accumulation of hydrogen sulfide, a gas that inhibits mitochondrial respiration. Here, we
show that, in mice, rats, and naturally hypoxia-tolerant ground squirrels, the sensitivity of the
brain to hypoxia is inversely related to the levels of sulfide:quinone oxidoreductase (SQOR)
and the capacity to catabolize sulfide. Silencing SQOR increased the sensitivity of the brain to
hypoxia, whereas neuron-specific SQOR expression prevented hypoxia-induced sulfide
accumulation, bioenergetic failure, and ischemic brain injury. Excluding SQOR from mito-
chondria increased sensitivity to hypoxia not only in the brain but also in heart and liver.
Pharmacological scavenging of sulfide maintained mitochondrial respiration in hypoxic neu-
rons and made mice resistant to hypoxia. These results illuminate the critical role of sulfide
catabolism in energy homeostasis during hypoxia and identify a therapeutic target for
ischemic brain injury.
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The brain is the most sensitive organ to hypoxia, presumablydue to the brain’s high metabolic demand, limited glycolyticcapacity, and reliance on oxidative phosphorylation1–4. The
mechanisms underlying the sensitivity of the brain to hypoxia are
incompletely understood. During aerobic respiration, adenosine
triphosphate (ATP) is predominantly produced by oxidative
phosphorylation using the electrochemical gradient produced via
the mitochondrial electron transfer chain (ETC). Molecular oxy-
gen serves as the terminal electron acceptor that binds and accepts
electrons from cytochrome c oxidase (COX, complex IV), the last
enzyme in the ETC. Approximately 90% of all oxygen consumed
by the body is used by COX in a reaction that reduces oxygen in
the presence of hydrogen to produce water. When brain tissue
PO2 reaches the “critical” level of 6–8mmHg5, there is a pre-
cipitous drop in cellular ATP concentration resulting in cata-
strophic energy failure in the brain6. Decreased ATP levels in the
brain occur within 2–3min of the onset of severe hypoxia and
cause the collapse of the ionic gradient leading to membrane
depolarization5,7. Persistent lack of oxygen beyond a few minutes
irreversibly damages neurons. Paradoxically, the re-introduction
of oxygen contributes to further injury8.
Cytochrome c oxidase has a high affinity for oxygen with a Km
of 0.03–0.3 mmHg, which is significantly lower than the mean
PO2 in the brain; the enzyme is saturated with its substrate (i.e.,
oxygen) under most physiological conditions5. Therefore, at the
critical brain tissue PO2 level of 6–8 mmHg, when ATP pro-
duction by oxidative phosphorylation drastically decreases, there
appears to be more than sufficient oxygen in the brain tissue for
COX to sustain normal electron flow in the ETC. This apparent
gap between the critical brain tissue PO2 level and the Km of COX
suggests that there is a role for additional factors that contribute
to the inhibition of ETC under hypoxic conditions.
In addition to oxygen shortage, several gases including
hydrogen sulfide (H2S), nitric oxide (NO), and carbon monoxide
inhibit mitochondrial respiration9. H2S is generally considered a
highly toxic substance for aerobic organisms as it inhibits
COX10,11. However, H2S also has a number of physiological
functions12. In mammalian cells, sulfides (H2S and HS−, which is
in equilibrium with H2S), or closely related reactive sulfur species
such as persulfides (RSSH) and polysulfides (RSnH), are generated
by enzymes including cystathionine β-synthase (CBS), cysta-
thionine γ-lyase (CSE), 3-mercaptopyruvate sulfurtransferase (3-
MST), and cysteinyl tRNA synthetase-2 (CARS2)13–15. Sulfides
are catabolized in mitochondria by sulfide oxidation enzymes.
The oxidation of sulfide to persulfide, catalyzed by SQOR, is
considered to be the first and rate-limiting step in sulfide
oxidation16. Persulfide is further oxidized to thiosulfate, sulfite,
and sulfate by persulfide dioxygenase (SDO or ETHE1), thio-
sulfate sulfurtransferase (TST), and sulfite oxidase (SUOX). While
SQOR is highly expressed in the liver, heart, lung, skeletal muscle,
and colon, the level of SQOR is low in the brains of most
mammals including mice, rats, and humans17 (https://www.
proteinatlas.org/ENSG00000137767-SQOR/tissue). Because the
brain of these animals has limited capacity to catabolize sulfide17,
the brain is particularly sensitive to the adverse effects of sulfide
accumulation. For example, loss of ETHE1 causes fatal sulfide
toxicity in ethylmalonic encephalopathy18. In addition, the defi-
ciency of SQOR was recently reported to cause Leigh syndrome-
like disease characterized by encephalopathy and the presence of
brain lesions in the basal ganglia and cortex19. These observations
suggest a critical role of sulfide catabolism in normal cerebral
energy homeostasis. However, the effects of sulfide catabolism on
brain bioenergetics during acute oxygen deprivation have thus far
attracted little attention.
Under physiological conditions, sulfide oxidation by SQOR
donates electrons to mitochondrial ETC complex III via
coenzyme Q (CoQ), thereby potentially promoting ATP
synthesis20–22. In addition, it has been suggested that persulfide
produced by SQOR-mediated sulfide oxidation may serve as an
electron acceptor from ETC, facilitating mitochondrial ATP
production15,23. However, hypoxia increases the production of
sulfide while inhibiting its oxidation, leading to sulfide
accumulation24–26. Hypoxia also impedes persulfide oxidation by
ETHE1 as this reaction requires oxygen16. Excess sulfide pro-
motes the production of NO and reactive oxygen species
(ROS)27–29, which, together with sulfide, impair oxidative phos-
phorylation during ischemia and increase reperfusion injury30.
Therefore, sulfide catabolism may play a pivotal role in cerebral
energy homeostasis during acute oxygen shortage and in sub-
sequent brain injury upon reoxygenation.
In this study, while examining the effects of chronic inter-
mittent H2S breathing in mice, we unexpectedly discovered that
upregulation of the capacity to catabolize sulfide makes mice
remarkably resistant to otherwise lethal hypoxia. Based on this
serendipitous discovery, we sought to elucidate the role of sulfide
metabolism in the sensitivity of the mammalian brain to hypoxia.
We report that increased sulfide oxidation by SQOR makes brains
resistant to hypoxia or cerebral ischemia. We also show that
pharmacologically scavenging sulfide, so as to avoid sulfide
accumulation in the brain, maintains mitochondrial energy pro-
duction during oxygen shortage and prevents ischemic or hypoxic
brain injury. Our study uncovers the critical role of sulfide cat-
abolism in mitochondrial energy homeostasis during hypoxia and
lays a foundation for a novel approach to the treatment of
ischemic or hypoxic brain injury.
Results
Sulfide-pre-conditioning induces hypoxia tolerance in mice.
Breathing H2S depresses metabolism and decreases the body
temperature of rodents31,32. However, as we previously showed,
intermittent breathing of H2S for 5 days makes male wild-type
mice tolerant to the hypo-metabolic effects of inhaled H2S
(Fig. 1a)33. Because chronic sulfide exposure might induce
enzymes that increase the capacity to metabolize sulfide, we
examined the impact of intermittent H2S breathing for 5 days
(sulfide pre-conditioning, SPC) on sulfide metabolism. Mice were
studied 24 h after the last H2S exposure (on the 6th day), when
the metabolism and body temperature of the mice had completely
recovered (Supplementary Fig. 1a). When control (not sulfide
pre-conditioned) mice acutely breathed H2S, there was a decrease
in whole-body metabolism, as measured by a decreased rate of
CO2 production (VCO2) (Fig. 1b). In contrast, in mice that were
pre-conditioned with H2S, subsequent acute H2S exposure had no
effect on VCO2. Breathing H2S increased plasma levels of sulfide
and thiosulfate to a similar extent in control and sulfide pre-
conditioned mice (Fig. 1c, d). However, breathing H2S increased
the levels of sulfide and thiosulfate only in the brains of control
mice, but not in the brains of sulfide pre-conditioned mice
(Fig. 1e, f). Thus, sulfide pre-conditioning may induce tolerance
to the inhibitory effects of H2S on metabolism by upregulating
sulfide catabolism in the brain.
In addition to increased tolerance to breathing H2S, sulfide pre-
conditioned mice exhibited marked tolerance to severe hypoxia
(5% O2) (Fig. 1g, h and Supplementary Fig. 1b). To examine the
impact of sulfide pre-conditioning on biochemical changes in the
brain during hypoxia, mice were anesthetized with isoflurane and
ventilated with 21% or 5% O2 for 3 min at 37 °C, and brains were
harvested and snap-frozen in liquid nitrogen. Breathing 5% O2
decreased brain tissue PO2 below the critical level of 6–8 mmHg
within 3 min (Supplementary Fig. 1c). Control mice (not pre-
conditioned with H2S) that breathed 5% O2 for 3 min had an
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acute increase in brain sulfide levels, to an extent similar to that
observed after breathing H2S at a dose (80 ppm), which inhibits
whole-body metabolism (Fig. 1b, e, i). Breathing 5% O2 also
increased brain persulfide levels in control mice (Fig. 1j).
Increased levels of sulfide in the brain of control mice were
accompanied by an increase in the NADH/NAD+ ratio and
lactate levels, indicating impaired oxidative phosphorylation
(Fig. 1k, l). In contrast, sulfide pre-conditioned mice breathing
5% O2 for 3 min were protected from sulfide accumulation and
decreased oxidative phosphorylation in the brain. In addition,
brain persulfide levels were decreased in sulfide-pre-conditioned
mice breathing 5% O2, suggesting enhanced persulfide consump-
tion during hypoxia (Fig. 1j). Taken together, the results suggest
that sulfide pre-conditioning prevents accumulation of sulfide
and inhibition of oxidative phosphorylation in the brain of mice
after acutely breathing either H2S at 80 ppm or 5% O2.
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Fig. 1 Effects of sulfide pre-conditioning on sulfide metabolism and hypoxia tolerance in mice. a Body temperature of control and sulfide pre-conditioned
(SPC) mice. “Pre” and “post” time points depict mice before and after breathing air (control) or H2S at 80 ppm for 4 h, respectively, from day 1 (D1) to day
6 (D6). bWhole-body CO2 production rate (VCO2) of SPC and control mice during H2S breathing on the 6th day after starting SPC or control air breathing.
Concentration of c sulfide (from left to right, n= 6, 8, 6, 6) and d thiosulfate (n= 6, 8, 6, 6) in plasma and concentrations of e sulfide (n= 6 each) and f
thiosulfate (n= 6 each) in the brain of SPC and control mice during H2S or air breathing on the 6th day. g Survival rate and h VCO2 of mice breathing 5%
O2 on the 6th day in control or SPC mice. Brain levels of i sulfide (n= 6, 6, 5, 5), j persulfide (n= 5 each), k NADH/NAD+ ratio (n= 5 each), and l lactate
levels (n= 5, 6, 7, 7) in control and SPC mice breathing at FiO2= 21% or 5% on the 6th day. m Relative mRNA levels of SQOR in the brain of SPC and
control mice (normalized as control= 1). n= 5 each. SQOR protein levels in n the brain tissue extracts (n= 9 each) and in o the heart (n= 10 each) from
control and SPC mice. Oxygen consumption rate (OCR) of isolated brain mitochondria from p control (n= 7) and q SPC (n= 6) mice with or without
incubation with sulfide (Na2S, 0, 1.5, 3.0 µM) and r calculated ATP turnover rates (n= 7, 7, 7, 6, 6, 6). Data are presented as mean ± SEM or mean and
individual values. #P < 0.05, ##P < 0.01, ###P < 0.001 vs Na2S at 0 µM of respective group. Two-way ANOVA followed by Sidak’s or Tukey’s correction for
post-hoc comparisons were performed for a–f, i–l, and r. Survival rates were estimated using the Kaplan–Meier method and a log-rank test was used to
compare the survival curves between groups in g. A two-tailed unpaired t-test was performed for m–o.
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To investigate the mechanisms responsible for the inhibition of
sulfide accumulation during hypoxia in mice pre-conditioned
with H2S, we measured the levels of enzymes that synthesize or
catabolize sulfide. Acquired tolerance to acute hypoxia in sulfide
pre-conditioned mice was associated with increased levels of
SQOR in the brain, but not in the heart presumably due to higher
baseline SQOR levels in the heart than in the brain (Fig. 1m–o
and Supplementary Fig. 1d). Increments of brain SQOR levels by
sulfide pre-conditioning temporarily coincided with the acquisi-
tion of hypoxia tolerance; sulfide pre-conditioning for 5 days, but
not 2 days, induced hypoxia tolerance and increased brain SQOR
levels (Supplementary Fig. 1e, f). Levels of other enzymes that
metabolize sulfide were not affected by sulfide pre-conditioning in
either brain or the heart (Supplementary Fig. 2a–c). Because
sulfide pre-conditioning increased SQOR levels in the brain, we
posited that sulfide pre-conditioning upregulates the ability of
brain mitochondria to catabolize sulfide and thereby prevents
sulfide-induced inhibition of oxidative phosphorylation. Sulfide
pre-conditioning did not affect baseline ATP turnover in isolated
brain mitochondria as determined by measuring oxygen
consumption rates (OCR). In control mice, incubation with
Na2S (a sulfide donor, that mimics hypoxia) dose-dependently
decreased ATP turnover in isolated mitochondria obtained from
the brain, but not liver that has high basal levels of SQOR (Fig. 1p
and Supplementary Fig. 3a–c). In contrast, the ability of Na2S to
depress ATP turnover in the brain mitochondria of sulfide pre-
conditioned mice was attenuated (Fig. 1q, r).
Although previous studies suggested that chronic exposure to
H2S increases mitochondrial biogenesis34, sulfide pre-conditioning
did not affect the levels of mitochondrial DNA in the brain or
heart of treated mice (Supplementary Fig. 4a). Chronic exposure
to hypoxia is known to increase red blood cell mass and the
oxygen affinity of hemoglobin35. However, five days of sulfide pre-
conditioning did not affect either hemoglobin levels or the oxygen
dissociation curve of murine red blood cells. Hydrogen sulfide was
previously shown to upregulate hypoxia-inducible factor-1α (HIF-
1α) and one of its canonical targets vascular endothelial growth
factor (VEGF) in vascular endothelial cells and to activate HIF-1α
in C. elegans36,37. Although sulfide pre-conditioning increased
mRNA levels of glucose transporter-1 (GLUT-1), mRNA levels of
VEGF, hemoxygenase-1 (HO-1), and erythropoietin (EPO), and
protein levels of VEGF, GLUT-1, and lactate dehydrogenase A
(LDAH) in the brain did not differ between control and sulfide
pre-conditioned mice at 24 h after the last H2S exposure when
mice were exposed to hypoxia (Supplementary Fig. 4b). Taken
together, these observations suggest that sulfide pre-conditioning
confers tolerance to hypoxia via upregulation of SQOR and sulfide
catabolism, rather than as a result of increased mitochondrial
biogenesis, increased oxygen delivery by hemoglobin, or upregula-
tion of canonical HIF-1α targets.
Sexual dimorphism of sulfide catabolism and hypoxia toler-
ance. Compared to the brains of 8-week old male CD-1 mice, the
brains of age-matched female CD-1 mice have ~3-fold and ~1.5
fold higher levels of SQOR mRNA and protein, respectively
(Fig. 2a, b). To investigate the effects of SQOR levels on the ability
of the murine brain to tolerate acute oxygen shortage, we sub-
jected CD-1 mice to hypoxia using environmental chambers. The
majority of female mice tolerated breathing 5% O2 for at least 1 h,
whereas all male mice died in less than 10 min (Fig. 2c). Of note,
higher SQOR levels in the brain of female mice appear to be
estrogen-dependent. Ovariectomy decreased mRNA and protein
levels of SQOR in the brain and abolished hypoxia tolerance in
female mice, whereas estrogen supplementation restored brain
SQOR mRNA levels and hypoxia tolerance and tended to restore
SQOR protein levels in ovariectomized female mice (Fig. 2d–f).
To investigate the role of SQOR in sulfide catabolism and
mitochondrial respiration, we examined the impact of exogenous
sulfide, which mimics hypoxia, on mitochondrial respiration in
suspensions of brain mitochondria isolated from male and female
mice. We used a custom-made spectrophotometer38 to simulta-
neously measure the ADP-induced changes in NADH levels,
mitochondrial membrane potential (ΔΨm, measured with tetra-
methylrhodamine, methylester, TMRM), and OCR before and
after addition of Na2S. In both male and female mice, in the
presence of pyruvate and malate (2.5 mM each), ADP (30 nmol)
stimulated oxidative phosphorylation, transiently decreased
NADH and ΔΨm, and increased OCR in brain mitochondria
(Fig. 2g–i). The addition of Na2S at 3 or 6 µM (final
concentration) inhibited the ADP-induced respiratory stimula-
tion in brain mitochondria from male mice (Fig. 2g, after 3rd
ADP addition), but not from female mice (Fig. 2h, after 3rd ADP
addition). These observations suggest that higher levels of SQOR
in female brain mitochondria confer resistance to hypoxia-
induced sulfide accumulation and inhibition of mitochondrial
respiration.
To further investigate whether increased brain SQOR levels are
responsible for the relative resistance of female mice to hypoxia,
we used shRNA targeting mouse Sqor (shSQOR) to knock down
SQOR. Adeno-associated virus vectors AAV-shSQOR or control
(AAV-Ctrl) were administered at 1010 viral particles per cerebral
hemisphere to newborn female CD-1 mice on postnatal day 0
(P0), via intracerebroventricular (ICV) injection, as described
previously (Fig. 2j)39. Eight weeks after administration of the
AAV, we observed widespread GFP expression in neurons
throughout the brain (Fig. 2k, l). Levels of SQOR mRNA, but
none of the other enzymes in the transsulfuration and sulfide
oxidation pathways, were significantly decreased throughout the
brain of mice infected with AAV-shSQOR (Fig. 2m and
Supplementary Fig. 5). Compared to 8-week-old control female
mice infected with AAV-Ctrl, age-matched female mice with
SQOR knockdown were more sensitive to hypoxia induced by
exposure to 5% O2 (Fig. 2n). These results support the hypothesis
that the higher levels of SQOR in the brains of female mice
resulted in a greater capacity to oxidize sulfide and contribute to a
greater tolerance to hypoxia.
Mice that lack SQOR in mitochondria exhibit higher sensitivity
to hypoxia. To elucidate the role of SQOR in mitochondrial
bioenergetics during oxygen deprivation, we developed mice that
lack SQOR in mitochondria. By using CRISPR-Cas9 technology,
we disrupted the translation start codon ATG of the murine Sqor
gene via a 14-bp deletion (Fig. 3a). This change led to the
initiation of translation starting at a downstream ATG, which
resulted in the production of SQOR protein that lacked the N
terminal mitochondrial localization sequence (SQORΔN)
(Fig. 3c). We confirmed that SQORΔN failed to localize to
mitochondria in mouse embryonic fibroblasts obtained from
SqorΔN/ΔN mice (Fig. 3d), although the lack of mitochondrial
localization sequence did not affect protein stability of SQORΔN
(Supplementary Fig. 6a).
SqorΔN/ΔN mice were born normally according to the predicted
Mendelian ratio. Although SqorΔN/ΔN mice were indistinguishable
from WT littermates before weaning, growth of the homozygous
mutant mice ceased around the weaning period (Fig. 3e). All
SqorΔN/ΔN mice gradually became emaciated, developed ataxia,
and died within 10 weeks of age, whereas heterozygote mice were
normal and similar to WT mice (Fig. 3f, g).
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To examine the role of SQOR in energy homeostasis and survival
of neurons in hypoxia, we isolated primary cortical neurons from
SqorΔN/ΔN and WT littermate embryos. SqorΔN/ΔN neurons had
higher levels of intracellular sulfide compared to WT neurons
(Fig. 3h), suggesting that SQOR has a critical role in the catabolism
of sulfide in neurons even under normoxic conditions. In addition,
the magnitude of the oxygen and glucose deprivation (OGD)-
induced increase in sulfide levels was markedly greater in SqorΔN/
ΔN compared to WT neurons. Reoxygenation after OGD decreased
cell viability more markedly in SqorΔN/ΔN than in WT neurons
(Supplementary Fig. 6b). Compared to 5-week-old WT mice,
SqorΔN/ΔN littermates had a shorter survival when exposed to 5.5%
O2 (Fig. 3i). When SqorΔN/ΔN and control mice breathed air, there
were no differences in the levels of sulfide and persulfide or in the
ratio of NADH/NAD+ in whole-brain tissue homogenates (Fig. 3j,
k and Supplementary Fig. 6c). Although breathing 5.5% O2 for 3
min increased levels of sulfide and persulfide and the ratio of
NADH/NAD+ in the brains of both genotypes, sulfide levels and
the ratio of NADH/NAD+ were higher in the brains of SqorΔN/ΔN
mice than in control mice. In contrast to the results observed in the
brains of WT mice, breathing 5.5% O2 did not affect the levels of
sulfide and persulfide or the ratio of NADH/NAD+ in the heart or
liver of WT mice (Fig. 3l-o and Supplementary Fig. 6d). However,
exposure to 5.5% O2 increased these metrics in the heart and liver of
SqorΔN/ΔN mice. These results indicate that mitochondrial SQOR
prevents the accumulation of sulfide and persulfide and decreased
oxidative phosphorylation induced by hypoxia not only in the brain









































































Fig. 2 Sexual dimorphism of SQOR expression in the brain. a Relative SQOR mRNA levels (n= 9 each) and b protein levels (n= 3 each) in male and
female CD-1 mice. Vin, vinculin. c Survival curve of male and female CD-1 mice breathing 5% oxygen. Effects of ovariectomy (OVX) and 17 beta-estradial
(E) replacement on d SQOR mRNA levels (n= 7, 6, 6) and e protein levels (n= 6, 5, 5) in the brain and f survival rate in hypoxia (5% O2) in female CD-1
mice. Impact of sulfide (Na2S) on ADP-induced changes in NADH levels, mitochondrial membrane potential (TMRM, tetramethylrhodamine methylester),
and oxygen consumption rates (OCR) in suspensions of isolated brain mitochondria from g male and h female WT mice. P/M, pyruvate/malate.
Representative traces of three independent experiments in each genotype. i Summary of OCR values in response to ADP before and after administration of
sulfide (Na2S, 0, 3, 6 µM) in experiments represented in g and h. n= 3 at each Na2S dose. j Structure of AAV containing shRNA against mouse SQOR
(AAV-shSQOR) under a U6 promoter for RNA polymerase III and control AAV (AAV-Ctrl). ITR, inverted terminal repeat, EGFP, enhanced green
fluorescent protein, CMV, cytomegalovirus, bGH, bovine growth hormone. k, l Representative immunofluorescence images of the brain sections of CD-1
mice stained with an anti-GFP antibody 8 weeks after injection of AAV-Ctrl into ICV. Image in l shows a blow-up of a part of the image in k enclosed in a
red box. n= 2 biologically independent experiments. m Relative SQOR mRNA levels in the brains of female CD-1 mice transfected with AAV-Ctrl or AAV-
shSQOR (n= 7, 6). n Survival curve of adult female CD-1 mice infected with AAV-Ctrl or AAV-shSQOR breathing 5% oxygen. Data are presented as mean
± SEM or mean and individual values. A two-tailed unpaired t-test was performed for a, b, and m. Survival rates were estimated using the Kaplan–Meier
method and a log-rank test was used to compare the survival curves between groups in c, f, and n. One-way or two-way ANOVA followed by Dunnett’s or
Tukey’s correction for post-hoc comparisons were performed for d, e, and i.
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Fig. 3 Generation of SQOR mutant mice and their increased sensitivity to hypoxia. a Schematic illustration of the murine Sqor gene structure and
sequences of WT and mutant alleles spanning the translation initiation codon. Blue letters and black letters indicate the first intron and the second exon,
respectively. ATG enclosed by a box indicates the first methionine codon. A target sequence of gRNA is underlined. Target sequences for genotyping
primers are indicated by arrows. b PCR detection of a deletion in the Sqor gene. Genomic DNAs from WT, SqorΔN/+, and SqorΔN/ΔN mice were amplified
with a primer set shown in a. Representative PCR gel images of 3 independent biological replicates of each are shown. c Schematic presentation of SQOR
proteins expressed by WT and SqorΔN alleles. d Immunoblot analysis of whole-cell lysates (Whole) and cytosolic (Cyto) and mitochondrial (Mito)
fractions of MEFs established from WT and SqorΔN/ΔN embryos. Representative immunoblots of 3 independent biological replicates for each are shown.
Protein samples were prepared for detection of SQOR, GAPDH (cytosolic marker), and SDHA (mitochondrial marker). e Macroscopic appearance of 5-
week-old WT, SqorΔN/+, and SqorΔN/ΔN littermate male mice. Scale bar, 1 cm. Representative images of more than three of each genotype are shown. f
Body weight gain and g survival rate of SqorΔN/ΔN mice (n= 20) compared with SqorΔN/+ mice and WT mice (n= 70). h Relative intracellular H2S levels
of primary cortical neurons obtained and cultured from SqorΔN/ΔN mice and their wild-type littermates embryos subjected to oxygen-glucose deprivation
(OGD). i Survival curve of SqorΔN/ΔN mice and their wild-type littermates breathing 5.5% oxygen. Relative levels of sulfide in j, l, n and the ratio of NADH/
NAD+ in k, m, o in the brain, liver, or heart, respectively, of SqorΔN/ΔN mice and their wild-type littermates breathing 5.5% oxygen (N= 5 each). Data are
presented as mean and individual values. Two-way ANOVA followed by Tukey’s correction for post-hoc comparisons were performed for h and j–l, n, and
o. Survival rates were estimated using the Kaplan–Meier method and a log-rank test was used to compare the survival curves between groups in i.
Kruskal–Wallis test followed by Dunn’s multiple comparisons was performed for m.
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Hypoxia-tolerant ground squirrels have a high capacity to
catabolize sulfide in the brain. Several mammalian species
including 13-lined ground (13LG) squirrels (Ictidomys tride-
cemlineatus) are highly resistant to oxygen deprivation
(Fig. 4a)40–42. To explore the relationship between sulfide meta-
bolism and natural hypoxia tolerance, we measured brain sulfide
levels in hypoxia-resistant 13LG squirrels and hypoxia-sensitive
Sprague-Dawley rats. Details of the 13LG squirrel model are
provided in the “Methods” section. Brain sulfide levels were
comparable between rats and 13LG squirrels breathing room air
(Fig. 4b). Breathing 5% O2 for 5 min decreased PaO2 to a similar
extent in rats and squirrels (Supplementary Fig. 7a). Levels of
sulfide and lactate and the ratio of NADH to NAD+ were
increased in the brains of rats when breathing 5% O2 (Fig. 4b-d).
Breathing 5% O2 also increased the levels of homocysteine, but
not GSH, thiosulfate, and cysteine, in the brains of rats (Sup-
plementary Fig. 7b). In contrast, exposure to 5% O2 did not affect
levels of sulfide, lactate, GSH, homocysteine, thiosulfate, and
cysteine and the ratio of NADH to NAD+ in the brains of 13LG
squirrels (Fig. 4b-d and Supplementary Fig. 7b). Metabolomic
analysis using GC-MS revealed increases in the levels of lactate,
fumarate, succinate, and cysteine in the brains of rats following
acute hypoxia, while only succinate was increased in the brains of
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Fig. 4 Hypoxia tolerance and enhanced sulfide catabolism in 13-lined ground squirrels. a 13 lined ground squirrel. Levels of b sulfide (n= 7, 7, 6, 6), c
lactate (n= 6 each), and d NADH/NAD+ ratio (n= 6 each) in brains of rats and 13LG squirrels (13 LGS) breathing 21% or 5% oxygen for 5 min under
isoflurane anesthesia. Volcano plots showing the changes in whole-brain metabolite profiles in response to breathing 5% oxygen in e rats and f 13LG
squirrels. Lac, lactate; Cys, cysteine; Fum, fumarate; Suc, succinate. g Immunoblots and protein expression levels of SQOR in forebrains of mouse, rat, and
13LG squirrel (N= 3 each). h SQOR enzyme activity in forebrains in mouse, rat, and 13LG squirrel (N= 6 each). ATP turnover rate and maximal respiratory
rate of isolated brain mitochondria measured as oxygen consumption rate (OCR) in i rats and j 13LG squirrels incubated with 0, 1, or 3 μM of Na2S (n= 6
each). k Structure of AAV containing shRNA against 13LG squirrel SQOR (AAV-shSQOR13LGS) under a U6 promoter for RNA polymerase III and control
AAV (AAV-Ctrl) containing scrambled shRNA. l Relative SQOR mRNA levels in the brain of 13LG squirrels infected with AAV-Ctrl (Control) or AAV-
shSQOR13LGS (shSQOR). Relative levels of m sulfide and n persulfide and o the ratio of NADH/NAD+ in the brains of Control or shSQOR-infected 13LG
squirrels breathing 5% oxygen under anesthesia. n= 6 each. Data are presented as mean ± SEM or mean and individual values. Two-way or one-way
ANOVA followed by Sidak’s correction for post-hoc comparisons were performed for b–d and g–j. Volcano plots were created using values in
Supplementary Table S1 and S2. A two-tailed unpaired t-test was performed for l, n, and o. Mann–Whitney U test was performed for m.
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and 2). These observations indicate that 13LG squirrel brains do
not accumulate sulfide under hypoxia and are resistant to
hypoxia-induced impairment of sulfide metabolism and oxidative
phosphorylation.
To investigate the mechanisms responsible for the tolerance of
13LG squirrels to the effects of cerebral hypoxia, we measured
SQOR levels in the brains of mice, rats, and 13LG squirrels.
SQOR protein levels in the brains of 13LG squirrels were ~100-
fold greater than that in the brains of mice and rats (Fig. 4g).
SQOR enzyme activity, measured as the capacity of brain tissue
homogenates to oxidize sulfide using coenzyme Q1 as an electron
acceptor43, was also markedly higher in 13LG squirrels than in
mice and rats (Fig. 4h). Protein levels of TST, a sulfide oxidation
enzyme downstream of SQOR, were also modestly higher in the
brains of 13LG squirrels compared to rats and mice (Supple-
mentary Fig. 7c). In contrast, the abundance and activities of
transsulfuration pathway enzymes were comparable between
mice, rats, and 13LG squirrels (Supplementary Fig. 7c, d).
To examine the effect of higher SQOR levels and activity on
brain mitochondrial function, we measured OCR in isolated brain
mitochondria of rats and 13LG squirrels at baseline and in the
presence of increasing doses of sulfide (mimicking the effects of
hypoxia). Sodium sulfide inhibited oxygen consumption in
mitochondria isolated from the brains of rats in a dose-
dependent manner. The ability of sodium sulfide to decrease
oxygen consumption was attenuated in mitochondria isolated
from the brains of 13LG squirrels, indicating a resistance of 13LG
squirrel brain mitochondria to the inhibitory effects of sulfide on
oxidative phosphorylation (Fig. 4i, j).
To investigate the role of SQOR in the ability of 13LG squirrels
to tolerate brain hypoxia, we designed and produced an AAV
containing an shRNA targeting 13LG squirrel Sqor (AAV-
shSQOR13LGS). This shRNA was the best of four candidate
sequences at decreasing the level of Sqor in myoblasts isolated
from 13LG squirrels (Supplementary Fig. 7e and Supplementary
Table 3). We packaged shRNA in the AAV9, which, compared to
serotypes AAV2, 4, and 8, exhibited the highest transfection
efficiency in 13LG squirrel brains (Supplementary Fig. 7f). We
administered AAV-shSQOR13LGS or a control AAV with a
scrambled sequence (AAV-Ctrl) into the cerebral ventricles of
13LG squirrels at 2.5 × 1011 viral particles per hemisphere
(Fig. 4k). Two weeks after AAV infection, brain SQOR mRNA
was decreased in squirrels that were infected with AAV-
shSQOR13LGS compared to those infected with AAV-Ctrl (Fig. 4l).
Control and SQOR knockdown 13LG squirrels were anesthetized
and ventilated with 5% O2 for 5 min. Compared to control
animals, the brains of SQOR knockdown squirrels had increased
levels of sulfide and persulfide (Fig. 4m, n). After exposure to 5%
O2, the ratio of NADH/NAD+ was higher in the brains of SQOR
knockdown squirrels than in the brains of control squirrels
(Fig. 4o). The results show that silencing SQOR results in
increased levels of sulfide and persulfide and decreased oxidative
phosphorylation in the brain of squirrels in response to hypoxia.
While there was some variability in the efficiency of SQOR
knockdown among animals, there was a negative linear correla-
tion between SQOR mRNA level and the ratio of NADH/NAD+,
whereas there was a positive linear correlation between brain
sulfide levels and NADH/NAD+ ratio (Supplementary Fig. 7g).
These observations indicate that the higher level of SQOR in the
brain mitochondria of 13 LG squirrels contributes to the
resistance of these animals to acute hypoxia.
SQOR facilitates ATP production in neuronal cells. To examine
the effects of increased sulfide oxidation on mitochondrial ETC
function, SQOR was expressed in the human neuroblastoma cell
line SH-SY5Y. The cells expressed very low levels of SQOR when
transfected with a control plasmid (Fig. 5a). Expression of SQOR
in SH-SY5Y cells incubated in 21% O2 resulted in increased
intracellular concentrations of persulfide, indicating that SQOR
expression enhanced sulfide oxidation (Fig. 5b). Expression of
SQOR did not affect ATP levels in isolated mitochondria incu-
bated in 21% O2 (Fig. 5c). However, when incubated with Na2S (a
sulfide donor) in 21% O2, mitochondria isolated from cells
expressing SQOR exhibited markedly increased ATP levels
compared to mitochondria isolated from control cells. These
observations suggest that sulfide oxidation by SQOR contributes
to cellular ATP production under normoxic conditions.
When SQOR-expressing and control SH-SY5Y cells were
incubated in 1% O2, SQOR prevented the hypoxia-induced
increase in sulfide, lactate, and ROS levels, and prevented the
hypoxia-induced increase in the NADH/NAD+ ratio (Fig. 5d–g).
In addition, expression of SQOR inhibited hypoxia-induced
decreases in ATP production and complex IV activity (Fig. 5h, i).
These results indicate that enhanced sulfide oxidation by SQOR
expression may prevent sulfide accumulation and the impairment
of mitochondrial ATP production during oxygen shortage.
Neuron-specific SQOR expression improves survival in
hypoxia. To determine whether enhanced sulfide oxidation confers
resistance to oxygen deprivation in vivo, we used an AAV encoding
mouse Sqor (AAV-SQOR) under the hSYN1 promoter to express
SQOR specifically in neurons of CD-1 mice (Fig. 6a). In the brains
of CD-1 mice treated with AAV-SQOR, the mRNA and protein
levels of SQOR, but none of the other proteins that metabolize
sulfide, were increased (Fig. 6b, c and Supplementary Fig. 8a and b).
Because male CD-1 mice are more sensitive to hypoxia than female
mice (Fig. 3c), male and female mice were treated with different
concentrations of oxygen. When an 8-week-old male or female
mice breathed 5.5% or 4.5% O2, respectively, mice that expressed
SQOR in the brain exhibited better survival rates compared to
control mice infected with AAV-GFP (Fig. 6d, e).
Because the effects of SQOR expression on indices of oxidative
phosphorylation were more robust in male than in female mice
presumably due to the lower (baseline) brain levels of SQOR in
males (Fig. 3a, b), only male mice were used in the following
experiments. SQOR expression prevented the hypoxia-induced
increase in the levels of sulfide and persulfide and the ratio of
NADH/NAD+ in the brain of male mice (Fig. 6f–h). Metabo-
lomic analysis was used to investigate the effects of hypoxia on
metabolites in the brain. Neuron-specific SQOR expression
mitigated the hypoxia-induced increase in the ratios of lactate/
pyruvate and succinate/fumarate in the brain of male mice that
breathed 5.5% O2 (Fig. 6I, j and Supplementary Fig. 8c,
Supplementary Tables 4 and 5).
To further define the effects of enhanced sulfide oxidation on
oxygen deprivation specifically in the brain, we examined the
impact of SQOR expression on brain injury induced by global
cerebral ischemia and reperfusion. Male mice were subjected to
global cerebral ischemia induced by 20 min of bilateral carotid
artery occlusion (2VO) followed by reperfusion. In control mice
that were infected with AAV-GFP and subjected to 2VO and
reperfusion, a number of Fluoro-Jade B (FJB)-positive dead
neurons were observed in the hippocampal CA1 and CA3 regions
(Fig. 6k–m) and cerebral cortex (Fig. 6n, o). In mice expressing
SQOR in neurons, only a few FJB-positive neurons were found in
the hippocampus and cortex after 2VO and reperfusion. The
number of viable neurons counted in H&E-stained brain sections
showed a reciprocal trend of the number of FJB-positive dead
neurons in these brain regions (Supplementary Fig. 9). After 2VO
and reperfusion, mice expressing SQOR exhibited better
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neurological function (Fig. 6p) and survival rate compared to
control mice (survival rate at day 3, 9/9 vs 6/12, respectively, P <
0.05). Taken together, these results suggest that neuron-specific
SQOR expression prevents sulfide accumulation and impairment
of mitochondrial respiration in the brain, improves survival in
severe hypoxia, and prevents ischemic brain injury and death
after global cerebral ischemia.
Sulfide scavenging prevents ischemic brain injury. The
mechanism by which enhanced sulfide oxidation by SQOR
increases ATP production is unknown. The predominant effect of
sulfide oxidation may be to directly provide electrons to the ETC.
Alternatively, the major effect of sulfide oxidation may be to
prevent sulfide-induced inhibition of mitochondrial complex IV
(Fig. 5i). Arguing against the first possibility, oxidation of sulfide
as a direct source of electrons is energetically unfavorable, espe-
cially during oxygen shortage. Compared to oxidation of NADH
or succinate (the canonical electron donors), sulfide oxidation
requires three times more oxygen for the same electron transfer in
the ETC30. We, therefore, hypothesized that the beneficial
effects of SQOR-mediated sulfide catabolism during oxygen
shortage are predominantly mediated by the avoidance of sulfide
accumulation, rather than the provision of electrons to ETC from
oxidizing sulfide. To test this hypothesis, we examined the effects
of pharmacological scavengers of sulfides on SH-SY5Y cells
incubated in 21% or 1% O2. Both the highly specific sulfide
fluoroprobe/scavenger HSip-1 and the broad-spectrum scavenger
hydroxocobalamin dose-dependently prevented the increase in
the ratio of NADH/NAD+ induced by 1% O2 (Fig. 7a). Hydro-
xocobalamin attenuated the low oxygen-induced increase in SH-
SY5Y intracellular sulfide levels (Fig. 7b), and improved survival
of cells subjected to oxygen and glucose deprivation (Fig. 7c) in a
dose-dependent manner. Although increased sulfide levels
observed in primary cortical neurons of SqorΔN/ΔN mice (Fig. 3h)
were associated with decreased oxygen consumption in isolated
brain mitochondria obtained from SqorΔN/ΔN mice, scavenging
sulfide by hydroxocobalamin partially restored OCR (Fig. 7d).
These results suggest that scavenging sulfide can restore mito-
chondrial energy homeostasis even when sulfide oxidation is
impaired.
In mice, global cerebral ischemia induced by 2VO decreased
SQOR activity in the brain, leading to increased sulfide levels and
the NADH/NAD+ ratio (Fig. 7e–g). Administration of sulfide
scavengers prevented sulfide accumulation and the increase in the
NADH/NAD+ ratio in the brain during global cerebral ischemia.





























































































































































































































Fig. 5 SQOR improves mitochondrial function in neuronal cells. a Immunoblots of SQOR in SH-SY5Y with mock transfection or SQOR expression (L, H:
low and high dose of transfection agent). Representative immunoblots of 2 independent biological replicates are shown. b Effect of SQOR expression on
Intracellular persulfide level in SH-SY5Y cell at 21% O2. n= 5 each. c ATP levels in mitochondria isolated from SH-SY5Y cells with or without SQOR
expression treated with Na2S at 0, 1, or 3 µM in the medium (n= 6 each). d Intracellular H2S (n= 12 each), e lactate in cell culture medium (n= 6 each), f
intracellular NADH/NAD+ ratio (n= 5 each), g intracellular ROS (n= 10 each), h intracellular ATP (n= 6 each), and i complex IV activity (n= 5 each) in
SH-SY5Y cells with or without SQOR expression in 21% or 1% O2. Cells were exposed to hypoxia or normoxia for 3 h starting at 48 h after transfection.
Data are presented as mean and individual values. A two-tailed unpaired t-test was performed for b. Two-way ANOVA followed by Sidak’s correction for
post-hoc comparisons were performed for c–i.
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Furthermore, treatment with hydroxocobalamin at 10 min after
the onset of focal brain ischemia markedly attenuated ischemic
brain injury and neurological dysfunction after permanent middle
cerebral artery occlusion (MCAO) without reperfusion (Fig. 7h–j)
and dose-dependently improved survival when mice were
exposed to 5.5% O2 (Fig. 7k). In contrast, cyanocobalamin, a
synthetic vitamin B12 that scavenges ROS, but not sulfide, did not
improve the survival of hypoxic mice44 (Fig. 7k). To further
examine the ability of sulfide scavengers to protect against the
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Fig. 6 Effects of SQOR expression in the brain of mice. a Structures of AAV containing mouse SQOR and enhanced GFP sequence under hSYN1 promoter
(AAV-SQOR) and control AAV (AAV-GFP). SV40, simian virus 40. Relative SQOR mRNA expression levels in brains of 8-week-old b male (n= 6, 10) and
c female (n= 7, 5) CD-1 mice transfected with AAV-GFP or AAV-SQOR on postnatal day 0. Survival curves of 8-week-old d male and e female CD-1 mice
transfected with AAV-GFP or AAV-SQOR on postnatal day 0 and breathing 5.5% oxygen and 4.5% oxygen, respectively. Levels of f sulfide (n= 6, 7, 6, 6),
g persulfide (n= 5 each), h the ratios of NADH/NAD+ (n= 6 each), i lactate/pyruvate (n= 6 each), and j succinate/fumarate (n= 6 each) in male mice
transfected with AAV-GFP or AAV-SQOR and breathed 21% or 5.5% oxygen for 3 min. k Representative photomicrographs of Fluoro-Jade B (FJB)-stained
brain sections focusing on hippocampal CA1 and CA3 regions of male mice transfected with AAV-GFP (n= 4) or AAV-SQOR (n= 6) and subjected to
2VO and reperfusion. Number of dead neurons in l CA1 and m CA3 regions of mice transfected with AAV-GFP or AAV-SQOR and subjected to 2VO (n=
4, 6). n Representative photomicrographs of FJB-stained brain sections focusing on cerebral cortex region of male mice transfected with AAV-GFP (n= 4)
or AAV-SQOR (n= 6) and subjected to 2VO and reperfusion. o Number of dead neurons in the cerebral cortex of mice transfected with AAV-GFP or
AAV-SQOR and subjected to 2VO (n= 4, 6). p Neurofunctional impairment score of male CD-1 mice transfected with AAV-GFP or AAV-SQOR and
subjected to sham surgery or 12 or 20min of 2VO (n= 6, 6, 7, 6, 6, 7). Data are presented as mean and individual values. A two-tailed unpaired t-test was
performed for b, c, l, m, and o. Survival rates were estimated using the Kaplan–Meier method and a log-rank test was used to compare the survival curves
between groups in d and e. Two-way ANOVA followed by Sidak’s correction for post-hoc comparisons were performed for f–j and p.
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clinically relevant model of transient (60 min) MCAO and
reperfusion and treated with the highly specific sulfide scavenger
SS-2045 45 min after the onset of ischemia. Treatment with SS-20
during ischemia markedly decreased the infarct size and
improved neurological function at 48 h after reperfusion without
changing CBF (Supplementary Fig. 10). These results suggest that
the prevention of sulfide accumulation is sufficient to maintain
energy homeostasis and neuronal survival during acute oxygen
deprivation in the brain.
Discussion
In hypoxic tissues, not only is there a lack of oxygen, but there is
also increased production of sulfide. In the brain, an organ with
limited capacity to oxidize sulfide, hypoxia-induced sulfide
accumulation results in decreased oxidative phosphorylation and
neuronal death (Fig. 7l, m). Our discovery that acceleration of
sulfide oxidation in the murine brain induces tolerance to
hypoxia prompted us to hypothesize that enhancement of sulfide
catabolism may prevent sulfide accumulation and mitigate the
impairment of mitochondrial energy homeostasis during oxygen
shortage, resulting in decreased ischemic brain injury. In the
current study, we observed that the degree of tolerance to hypoxia
correlates with brain levels of SQOR in mice, rats, and 13LG
squirrels. Decreasing the cellular level of SQOR or preventing the
mitochondrial localization of the enzyme makes the brains more
sensitive to oxygen shortage, whereas neuron-specific expression
of SQOR makes mice highly resistant to hypoxia and cerebral
ischemia (Fig. 7n). We also showed that scavenging sulfide
maintains oxidative phosphorylation during oxygen shortage and
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prevents ischemic brain injury in mice (Fig. 7o). Our observations
illuminate a critical role of sulfide catabolism in facilitating the
brain’s resistance to acute oxygen deprivation. These results
suggest that enhanced sulfide catabolism may be an effective
therapeutic approach to the treatment of hypoxic or ischemic
brain injury.
The role of sulfides in hypoxia or ischemia has been a focus of
intense investigation in the last decade. Although sulfide levels
increase during hypoxia and decrease after reoxygenation in
several tissues, including the brain, the functional significance of
the changes in sulfide levels in hypoxic tissue remained
elusive24,26,46,47. While increasing sulfide levels by administration
of exogenous sulfide donors prevented ischemic brain injury in
some studies48,49, decreasing sulfide levels by inhibition of
sulfide-producing enzymes were also protective in other
studies50,51. In the current investigation, we observed that
breathing 5% oxygen for 3 min increased brain sulfide levels in
mice to a similar extent as breathing H2S at 80 ppm, which is
sufficient to inhibit whole-body oxygen consumption (via inhi-
bition of COX) by ~90%31,32. These results indicate that the levels
of sulfide induced by a brief period of hypoxia are sufficient to
inhibit COX in the brain. We also observed that sulfide pre-
conditioning upregulates SQOR expression in the brain and
abrogates the ability of breathing 5% O2 or 80 ppm H2S to
increase sulfide levels in the brain. Sulfide pre-conditioning
enhances the ability of brain mitochondria to withstand the
inhibitory effects of sulfides on oxidative phosphorylation by
upregulating SQOR and thereby makes mice tolerant to hypoxia.
These results suggest that upregulation of SQOR confers bene-
ficial effects during oxygen shortage in the brain.
Recent studies suggest that reactive persulfide has critical roles
in mitochondrial bioenergetics15. In the current study, we
observed that, along with sulfide, persulfide accumulated in
hypoxic brains. Increased levels of SQOR prevented the hypoxia-
induced persulfide accumulation in the brain, while persulfide
accumulated in the brains and livers of hypoxic SqorΔN/ΔN mice.
These observations indicate that, in addition to sulfide, persulfide
is produced in hypoxic brains and catabolized by SQOR (either
directly or indirectly after reduction to sulfide). Akaike and col-
leagues suggested that persulfide may serve as an electron acceptor
from ETC15. Therefore, in hypoxic tissues with high SQOR levels,
SQOR-dependent oxidation of sulfide and persulfide donate
electrons to ETC, and persulfide may be reduced to sulfide by
accepting electrons from ETC. SQOR may maintain mitochon-
drial energy homeostasis during hypoxia not only by preventing
sulfide-induced COX inhibition but also by producing persulfide.
Because sulfide pre-conditioning and enhanced tolerance to
hypoxia were associated with upregulation of SQOR in the brain,
we posited that SQOR might also has a role in natural hypoxia
tolerance. Previous studies of brain ischemia in a variety of ani-
mal models showed that, compared to male animals, females
sustain less tissue damage than males after comparable
insults52,53. The protective effect of the female gender is lost after
ovariectomy but can be restored by estrogen supplementation54.
In the current study, we found that the tolerance of female mice
to hypoxia was associated with higher levels of SQOR in the brain
compared to male mice. Isolated brain mitochondria from female
mice were resistant to the inhibitory effects of sulfide on oxidative
phosphorylation. Ovariectomy decreased brain SQOR levels and
abolished hypoxia tolerance in female mice, whereas estrogen
supplementation tended to increase brain SQOR levels and
restored resistance to hypoxia in ovariectomized female mice.
Silencing SQOR in the brain made female mice sensitive to
hypoxia. These observations support the hypothesis that higher
levels of SQOR in the brain enable hypoxia tolerance.
Several mammalian species exhibit robust resistance to severe
oxygen deprivation at levels that are invariably lethal to other
mammals. For example, 13LG squirrels can survive in 4.5% O2, a
level that is lethal to rats40. Nonetheless, the mechanisms
responsible for the marked tolerance of ground squirrels to
hypoxia were previously unknown. In the current study, we found
that the brains of 13LG squirrels have a ~100-fold higher level of
SQOR and a greater capacity to oxidize sulfide compared to mice
and rats. Breathing 5% O2 for 5 min increased levels of sulfide,
lactate, succinate, fumarate, and the ratio of NADH/NAD+ in the
brains of rats, whereas hypoxia increased only succinate in the
brains of 13LG squirrels. Succinate is the universal mitochondrial
feature of tissue hypoxia55. The observed isolated increase of
succinate confirms that the brains of 13LG squirrels are experi-
encing severe hypoxia, but protected from impairment of oxi-
dative phosphorylation. Of note, knockdown of SQOR restored
the ability of hypoxia to increase sulfide levels and the ratio of
NADH/NAD+ in the brains of 13LG squirrels. These results
suggest that high SQOR levels in the brain of 13LG squirrels
prevent hypoxia-induced sulfide accumulation and inhibition of
oxidative phosphorylation during hypoxia.
Friederich and colleagues recently reported two families that
have mutations in the Sqor gene that severely decrease SQOR
protein stability and enzyme activity19. Three individuals of these
families developed Leigh syndrome-like encephalopathy triggered
by acute infectious episodes and two of them died at young ages
(younger than 8 years old). Liver and muscle tissue from one of
Fig. 7 Effects of sulfide scavenger. a NADH/NAD+ ratio in SH-SY5Y cell lysates 3 h after incubation in hypoxia or normoxia with varying doses of HSip-1
or hydroxocobalamin (OHCb). n= 5 each. ***P < 0.001 vs normal saline (NS) at nomoxia. ###P < 0.001 vs NS at hypoxia. b Relative sulfide levels in SH-
SY5Y incubated in normoxia or hypoxia in the presence of varying concentrations of OHCb. n= 5 each. c Cell viability of SH-SY5Y subjected to oxygen and
glucose deprivation (OGD) in the presence of varying levels of OHCb, assessed by crystal violet assay. n= 10 each. ***P < 0.001, ##, ###P < 0.1, 0.001 vs
OHCb 0 μM. d Oxygen consumption rate (OCR) was measured in isolated brain mitochondria from SqorΔN/ΔN mice with or without OHCb and compared
to isolated mitochondria of wild-type littermates treated with vehicle (n= 4 each). e SQOR activity (n= 5 each) and f sulfide levels (n= 6, 6, 7, 6) in the
brains of mice subjected to sham operation or 2VO and treated with saline or OHCb. g NADH/NAD+ ratio in the brains of sham-operated mice or in mice
5min after the start of 2VO treated with vehicle (V), HSip-1 (HS), or OHCb (n= 6 each). h Representative photographs of the TTC staining of coronal
brain sections of male mice subjected to permanent MCAO and treated with normal saline (NS) or OHCb. i Brain infarct volume and j neurologic function
in male mice after 2VO and reperfusion (n= 5, 4). k Survival curve of male CD-1 mice treated with OHCb, cyanocobalamin (CCb), or normal saline
breathing 5.5% oxygen. Diagram illustrating working hypothesis on the role of SQOR and sulfide on mitochondrial energy production during l normoxia, m
hypoxia, n hypoxia with SQOR expression, and o hypoxia with sulfide scavenger. TSP, transsulfuration pathway. TST, thiosulfate sulfurtransferase. ETHE1,
ethylmalonic encephalopathy 1. TCA, tricarboxylic acid cycle, or Krebs cycle. Mitochondrial electron transport chain (ETC) complex are shown with roman
numerals in boxes. Data are presented as mean and individual values. Two-way ANOVA followed by Tukey’s or Sidak’s correction for post-hoc
comparisons were performed for a–d and f. Two-tailed unpaired t-test was performed for e, i, and j. One-way ANOVA followed by Tukey’s correction for
post-hoc comparisons were performed for g. Survival rates were estimated using the Kaplan–Meier method and a log-rank test was used to compare the
survival curves between groups in k.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-23363-x
12 NATURE COMMUNICATIONS |         (2021) 12:3108 | https://doi.org/10.1038/s41467-021-23363-x | www.nature.com/naturecommunications
these patients showed markedly decreased complex IV activity.
Although tissue sulfide levels were not measured in these indi-
viduals, these authors speculated that complex IV activity was
inhibited by the accumulation of H2S induced by decreased
SQOR activity. In the current study, SqorΔN/ΔN mice exhibited
emaciation, ataxia, and short life span, recapitulating clinical
features of Leigh syndrome. Primary cortical neurons of SqorΔN/
ΔN mice showed increased H2S levels and decreased mitochon-
drial oxygen consumption under normoxic conditions. These
observations suggest that SQOR is required for normal mito-
chondrial function and postnatal growth. In addition, SqorΔN/ΔN
mice may represent a novel mouse model of Leigh syndrome.
The results in the study of SqorΔN/ΔN mice support the
hypothesis that sulfide and persulfide may be used as electron
donors in tissues with high native SQOR expression levels such as
heart and liver. Exposure to 5.5% O2 increased levels of sulfide
and persulfide and the ratio of NADH/NAD+ only in the brain,
but not in the heart and liver, of wild-type mice. However, in
SqorΔN/ΔN mice, breathing 5.5% O2 increased levels of sulfide and
persulfide and the ratio of NADH/NAD+ in the heart and liver,
and exaggerated the hypoxia-induced increase in sulfide levels
and the ratio of NADH/NAD+ in the brain. These observations
suggest that basal levels of SQOR expression in the heart and
liver, but not in the brain, are sufficient to catabolize sulfides and
maintain oxidative phosphorylation when breathing 5.5% O2 for
3 min. This hypothesis is corroborated by the lack of SQOR
upregulation in the heart by sulfide pre-conditioning; basal SQOR
levels in the heart are sufficient to catabolize sulfide during
intermittent H2S inhalation. However, deficiency of SQOR in
mitochondria in SqorΔN/ΔN mice increased the sensitivity of heart
and liver to hypoxia. It is currently unknown how many electrons
are donated to the ETC by oxidation of sulfides by SQOR, in
addition to those donated by oxidation of canonical electron
donors such as NADH and succinate. However, our results sug-
gest that, compared to the brain, the ability of organs with high
SQOR levels to use sulfides as electron donors makes these organs
more resistant to oxygen deprivation.
Because sulfide oxidation to persulfide by SQOR donates
electrons via CoQ10 to complex III21,22, disposal of excess sulfide
and supplying electrons to ETC are inseparable functions of
SQOR. Therefore, pharmacological sulfide scavenging may be
only part of the explanation for the beneficial effects of SQOR-
dependent sulfide oxidation in hypoxic brains. The partial
restoration of oxygen consumption rates by sulfide scavenging in
the brain mitochondria of SqorΔN/ΔN mice supports this
hypothesis. Sulfide scavenging did not affect CBF during and after
cerebral ischemia and sulfide pre-conditioning did not induce
VEGF in the brain. These observations suggest that the beneficial
effects of sulfide scavenging or SQOR during hypoxia are unlikely
to be mediated by increasing CBF or promoting cerebral angio-
genesis. It is of note that three sulfide scavengers (hydro-
xocobalamin, HSip-1, and SS-20) with distinct chemical
structures exhibit robust protective effects in hypoxic or ischemic
brains. Hydroxocobalamin (vitamin B12) is safe in humans and
has been approved for the treatment of cyanide poisoning by the
US FDA. Given the paucity of neuroprotective measures against
hypoxic or ischemic brain injury, further studies examining the
neuroprotective effects of sulfide scavengers are warranted.
There are limitations in the current study. We did not inves-
tigate how acute hypoxia increases sulfide levels in the brain.
Sulfide levels are determined as a balance between sulfide
synthesis and catabolism. It has been suggested that hypoxia
decreases sulfide oxidation thereby increasing sulfide levels24. Our
observation that 2VO decreased SQOR activity and increased
sulfide levels in the mouse brain supports this hypothesis. While
we used a sulfide donor Na2S as a “substitute” for hypoxia in
experiments in isolated mitochondria, response to sulfide and
hypoxia may not overlap. Effects of SQOR in mitochondrial
energy homeostasis remains to be determined under hypoxic
condition. Although we did not find upregulation of canonical
HIF-1α targets in the mouse brain when mice were exposed to
hypoxia at 24 h after the last H2S inhalation, the role of HIF-1α in
the induction of hypoxia tolerance of sulfide-pre-conditioned
mice remains incompletely defined. H2S has been reported to
inhibit56 or activate HIF-1α37. It is possible that sulfide pre-
conditioning induces SQOR via HIF-1α activation. Interaction
between HIF-1α and sulfide oxidation pathway in hypoxia tol-
erance remains to be elucidated in future studies.
In conclusion, the current study demonstrates a critical role of
sulfide catabolism in cellular energy homeostasis. Our results
suggest that the relatively low level of SQOR makes most mam-
malian brains particularly vulnerable to oxygen deprivation,
whereas higher levels of SQOR may contribute to the increased
resistance to hypoxia exhibited by other tissues. Acceleration of
sulfide catabolism or pharmacological sulfide scavenging during
ischemia may make the brain more resistant to ischemia and
provide a novel preventive or therapeutic approach to ischemic/
hypoxic brain injury.
Methods
Animal protocols were approved by the Massachusetts General Hospital Institu-
tional Animal Care and Use Committee. Sprague-Dawley rats and CD-1 mice were
purchased from Charles River Laboratory (Wilmington, MA). C57BL6/J mice were
purchased from Jackson Laboratory (Bar Harbor, ME). SqorΔN/ΔN mice were
generated in Tohoku University and transferred to and maintained at Massachu-
setts General Hospital. All mice were housed with a 12 h dark/light cycle at a
temperature between 20 and 25 °C and a humidity between 40% and 60%.
Thirteen-lined ground squirrels (13LGS) were purchased as weanlings from the
University of Wisconsin Oshkosh Squirrel Colony. The design of experiments
involving animal subjects followed the ARRIVE guidelines. To minimize varia-
bility, we used a randomized paired (a.k.a. matched pairs) design. We paired mice
to two or more treatment groups on the basis of similar weight, age, delivery date,
and when possible holding cage.
Intermittent H2S inhalation. Adult male C57BL6/J mice were used in these
experiments. The mice assigned to sulfide pre-conditioning by H2S breathing were
exposed to air containing 80 ppm of H2S (Airgas Inc., Radnor, PA) for 4 h on each
of 5 consecutive days (Day 1 through Day 5), as previously described33. H2S
concentration, as well as FiO2, was continuously measured using a portable gas
monitor (ITX Multi-Gas Monitor, Industrial Scientific Corporation, Oakdale, PA).
Rectal temperature was measured pre- and post- H2S inhalation each day to
examine the influence of H2S on body temperature.
Measurements of CO2 production. Twenty-four hours after the last air or H2S
inhalation, CO2 production was measured in control or sulfide-pre-conditioned
mice. After mice were placed in individual chambers (Buxco Electronics, Inc.,
Wilmington, NC), CO2 production was measured with the LI-820 CO2 Gas
Analyzer (LI-COR Biosciences, Lincoln, NE). Mice breathed air for 1 h and
exposed to H2S at 80 ppm or 5% oxygen32.
Hypoxic breathing and tissue harvesting in mice. To measure hypoxia tolerance,
24 h after the last air or H2S inhalation, control or sulfide-pre-conditioned mice
were placed into a clear 1 L plastic chamber. Thereafter, the chamber was flushed
continuously at 1 L/min with gas mixtures to achieve the desired FiO2. Using an
oxygen monitor (Industrial Scientific Corporation, ITX multi-gas monitor equip-
ped with sampling pump model ISP), we determined that chamber air turnover
time was 228 ± 10 s. Mice were observed continuously for a maximum of 60 min
during hypoxia exposures, and were removed from the chamber when mice
exhibited signs of severe distress (wriggle or seizure, respiratory rates less than 6
per min, and incontinence) and euthanized with 5% isoflurane and counted as
dead. We used different inspired oxygen levels in differing strains and gender of
mice based on our pilot studies. For brain tissue harvesting, mice were anesthetized
with isoflurane (induction 4%, maintenance 1.5%), intubated with a 20-G catheter,
and mechanically ventilated (Harvard Apparatus, Mini Vent Ventilator Model 845)
with a tidal volume of 8 µL/g body weight/stroke and 120 strokes/min. After 3 min
of ventilation with air or hypoxic gas mixture, mice were euthanized with exsan-
guination and their forebrains were quickly harvested after perfusion with ice-cold
PBS. Each hemisphere after removing cerebellum and olfactory bulbs were frozen
in liquid nitrogen and stored at −80 °C until further assays.
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Generation of mitochondria-specific SQOR-deficient mice. All experimental
procedures conformed to the Regulations for Animal Experiments and Related
Activities at Tohoku University, were reviewed by the Institutional Laboratory
Animal Care and Use Committee of Tohoku University, and were approved by the
President of the University. We generated Sqor-deficient mice as follows. We used
B6D2F1 (C57BL/6NCr × DBA/2Cr F1) mice to obtain unfertilized eggs, and we
fertilized these eggs in vitro. In vitro fertilization was performed according to a
standard protocol with the B6D2F1 strain. After a 3-h culture of oocytes and
sperm, the eggs were removed and cultured for 5 h until electroporation. The
Genome Editor electroporator and LF501PT1-10 platinum plate electrode (length:
10 mm, width: 3 mm, height: 0.5 mm, gap: 1 mm) (BEX Co. Ltd., Tokyo, Japan)
were used for electroporation. We introduced Cas9/gRNA ribonucleoproteins
consisting of the Cas9 protein in complex with a targeting gRNA into fertilized eggs
with electroporation, according to protocols previously reported57, after which we
transferred the eggs to oviducts of pseudo-pregnant females on the day of the
vaginal plug. The sequence of the gRNA was designed as follows: 5′-
TATCCTGGTGATGGCCCCAC-3′, located at exon 2 of the Sqor gene to generate
Sqor-mutant mice. A founder mouse harboring the Sqor-mutant allele with a 14-bp
deletion spanning the translation initiation codon in exon 2 (SqorΔN) was crossed
with WT mice to obtain Sqor heterozygous (SqorΔN/+) mice. SqorΔN/+ mice were
back-crossed to the C57BL/6j background for more than six generations. Geno-
typing was performed by means of PCR and gel electrophoresis of the PCR pro-
duct. The genotyping primers were 5′-TGCTTCCTTTTAGCCTGATCTA-3′ and
5′-AAAACAGGCAAAGAGCCGGG
CAC-3′.
Establishment of immortalized MEFs. WT and SqorΔN/ΔN immortalized MEFs
(iMEFs) were established from mouse embryos at E13.5 and immortalized by the
lentiviral introduction of SV40 large T antigen. WT and SqorΔN/ΔN embryos were
obtained from SqorΔN/+ pregnant females mated with SqorΔN/+ males. Stable
transformants were selected via 2 µg/mL puromycin, and three independent WT
iMEF lines and SqorΔN/ΔN iMEF lines were established.
Immunoblot analysis of MEFs. Mitochondrial fractions were isolated from WT
and mitochondria-specific Sqor-deficient iMEFs as previously described58. Briefly,
cells were homogenized in isotonic buffer (10 mM HEPES, pH 7.4, 75 mM sucrose,
225 mM mannitol, and 2 mM EDTA) with a Teflon homogenizer for 50 strokes at
1600 rpm and centrifuged at 700 × g at 4 °C for 10 min. The supernatants were
centrifuged again at 5000 × g at 4 °C for 10 min. The pellets were washed twice with
the isotonic buffer and used as mitochondrial fractions. The soluble fractions
obtained by this process were filtered through a 0.22-mm filter and used as cyto-
solic fractions. Western blot analysis was performed by using anti-SQOR (poly-
clonal antibody raised in house), anti-GAPDH (Santa Cruz Biotechnology, Santa
Cruz, CA, USA; clone: sc-25778), and anti-SDHA (succinate dehydrogenase sub-
unit A) (Abcam, Cambridge, UK; clone: ab14715). The polyclonal antibody for
mouse SQOR was produced by immunizing rats with recombinant mouse SQOR.
Samples were solubilized with Laemmli lysis buffer (125 mM Tris-HCl, 2% SDS,
20% glycerol, and 10% 2-mercaptoethanol, pH 6.8), loaded on SDS-PAGE, and
transferred to polyvinylidene fluoride membranes (GE Healthcare, Little Chalfont,
England). The membranes were blocked with Blocking One (Nacalai Tesque,
Kyoto, Japan) at room temperature for 60 min and were incubated with primary
antibodies (1/5000) diluted by Can Get Signal Immunoreaction Enhancer Solution
1 (TOYOBO, Osaka, Japan) at 4 °C overnight. After membranes were washed with
TBST buffer (50 mM Tris-HCl, 150 mM NaCl, 0.1% Tween 20, pH 7.4), they were
incubated with horseradish peroxidase-conjugated secondary antibody (1/5000)
diluted by Can Get Signal Immunoreaction Enhancer Solution 2 (TOYOBO) at
room temperature for 1 h. Immunoreactive bands were detected by using an ECL
Prime Western Blotting Detection Reagent (GE Healthcare) with a luminescent
image analyzer (ImageQuant LAS 500; GE Healthcare).
The 13-lined ground squirrel hypoxia model. We selected the 13LGS as a natural
model of the hypoxia-tolerant animal as it amenable to laboratory housing, can be
acquired from a USDA-certified breeding colony in the US, and is a rodent species
that can be weight-matched for comparison with young Sprague-Dawley rats (a
hypoxia intolerant rodent). However, this species of ground squirrel (Ictidomys
tridecemlineatus) is also an obligate seasonal hibernator, with distinct phenotypes
between summer and winter and requiring varied seasonal housing conditions.
During the winter season, 13LGS will naturally fast and exhibit bouts of torpor over
2–3 week periods, in which body temperature declines to near ambient, and vital
rates precipitously drop59. These bouts are punctuated by short periods of
euthermy (12–18 h) in which vital rates and body temperature return to summer
levels (a body temperature trace of a 13-lined ground squirrel hibernating in the
laboratory is provided in Supplementary Fig. 11a). Ground squirrels were main-
tained in standard rodent housing (~22 °C) in summer (June–October) with a light
cycle 14 L:10D and fed ad libitum on sunflower seeds, dehydrated vegetables, and
dog food, then transferred to a temperature-controlled chamber and housed at 4 °C
in the dark from October–March, as previously described60. To monitor the ani-
mals during the hibernation season and to identify interbout euthermic periods
that occur between torpor bouts, core body temperature of the ground squirrels
was tracked using temperature telemeters (DSI TA-F10) implanted into the peri-
toneal cavity; this surgical procedure has been previously described60.
The cerebral hypoxia tolerance of 13LGS has not yet been completely
characterized, although several metrics indicate that ground squirrels demonstrate
intrinsically superior tolerance than non-hibernators such as rats61. One important
consideration for this model is the possibility that dramatic seasonal shifts in
phenotype with the onset of hibernation may affect metabolic and biochemical
parameters of interest, including cerebral hypoxia tolerance. As a result, we have
primarily focused on summer tissue collections for 13LGS to avoid any
confounding metabolic impacts of hibernation, although we have included some
animals collected in winter to bolster sample sizes, which we note in
Supplementary Table 6. Any tissues from winter animals included in this dataset
were collected during the euthermic interbout arousal period (Supplementary
Fig. 11a). We also conducted pilot studies to confirm that seasonal phenotypes did
not affect key parameters of interest, such as the abundance and activity of the H2S
signal transduction pathway. 13LG squirrels did not show seasonal changes in
responses to acute hypoxia breathing, in terms of the levels of sulfide, lactate, and
the ratio of NADH/NAD+ in the brain (Supplementary Fig. 11b–d). There were
also no seasonal differences in the protein levels of enzymes that metabolize sulfide
in the brains of 13LG squirrels (Supplementary Fig. 11e–k), nor differences in H2S
pathway enzyme activities.
Hypoxic breathing and tissue harvesting in rats and 13LG squirrels. To
investigate cerebral hypoxia tolerance, forebrains of rats and 13LG squirrels were
harvested during acute hypoxia exposures (FiO2 5% for 5 min). For tissue collec-
tions, rats and 13LG squirrels were anesthetized with isoflurane (induction with 5%
isoflurane) with spontaneous breathing (maintenance with 1.5–3.5% isoflurane),
then placed on a heating pad (FHC, Inc., DC Temperature Control System) to
maintain the rectal temperature at 37.3 ± 0.3 °C which is the physiological tem-
perature of healthy rats measured by a flexible wire probe (Physitemp Instruments,
Inc., IT-18). We cannulated the femoral artery in a subset of rats and 13LGS (PE10
polystyrene catheter) to collect serial blood samples for PaO2 analysis (LifeHealth,
IRMA TRUPOINT Blood Analysis System). Inspired O2 (FiO2) was monitored
throughout the procedure (Industrial Scientific Corporation, ITX multi-gas
monitor equipped with a sampling pump model ISP). After breathing air (FiO2=
21%) or hypoxic gas (5% O2 for 5 min), rats and 13LG squirrels were euthanized by
exsanguination under deep anesthesia and perfused with ice-cold PBS via the left
ventricle, then their forebrains were harvested. In normoxic animals, the cerebral
cortex from the right hemisphere was dissected using forceps and processed
immediately to measure mitochondrial oxygen consumption rate (OCR). In both
normoxic and hypoxic animals, the left forebrain was snap-frozen after removing
cerebellum and olfactory bulbs, then pulverized in liquid nitrogen to obtain a
homogeneous sample, and stored at −80 °C until biochemical assays.
To evaluate the effect of SQOR knockdown on cerebral outcomes of acute
hypoxia exposure, we conducted a similar experiment in 13LG squirrels infected
with AAV (AAV-SQOR13LGS or AAV-Ctrl; design of knockdown agent and AAV
injection procedures are described below). These animals were induced with
isoflurane in a chamber (5% isoflurane), then maintained on 1–3% isoflurane using
mechanical ventilation (Harvard Apparatus, Inspira asv, 50 breaths/min, tidal
volume 8.5–10 mL/kg, PEEP= 3 cm H2O). Anesthesia with mechanical ventilation
was supported by rocuronium bromide (1 mg/kg) and fentanyl (50 µg/kg) delivered
IP. A femoral artery cannula was placed in all animals to monitor blood gases
throughout the procedure. Rectal body temperature was maintained at 36.7 ±
0.3 °C which is the physiological temperature of healthy 13LGS. We also supported
blood pressure during the procedure by delivering 2cc warmed saline SQ upon
induction of anesthesia.
Sulfide measurement by high-performance liquid chromatography (HPLC). To
measure sulfide levels, we performed a fluorescent-based HPLC as reported
previously62. Briefly, brain tissues were homogenized in 100 mM Tris-HCl buffer
(pH 9.5, 0.1 mM diethylenetriaminepentaacetic acid) and centrifuged at 15,000 × g
× 10min × 4 °C. Supernatant (30 µL) was added to the mixture of Tris-HCl buffer
(70 µL) and monobromobimane (50 µL, 10 mM in acetonitrile), incubated at RT
for 30 min in the dark, then 5-sulfosalicylic acid (50 µL, 200 mM) was added to stop
the reaction and stabilize monobromobimane-labeled molecules. The solution was
placed on ice for 10 min and centrifuged. The recovered supernatant was then
analyzed using HPLC equipped with a multi λ fluorescence detector (Waters 2475,
Waters, Inc.).
Sulfide measurement by a H2S-specific fluorescent probe. To measure sulfide
levels, we used H2S-specific fluorescent probes HSip-1 and HSip-1 DA for tissue
homogenates and cultured cells, respectively, as reported previously63. For tissue
sulfide levels, brains were homogenized in HSip-1 solution (10 µM) in PBS that was
deoxygenated by passing nitrogen bubbles. Lysates were centrifuged at 15,000 × g
for 10 min at 4 °C. Supernatant was transferred into a 96-well plate, incubated in
the dark for 20 min at RT, then fluorescence was measured using a microplate
reader (SpectraMax i3x, Molecular Devices, Inc.). For sulfide levels in cultured cells
seeded in a 96-well plate, 10 µM HSip-1 DA was added to the culture medium
immediately after exposure to 1% O2 and incubated for 20 min at 37 °C in O2
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(5%)/air (95%). Cells were washed twice with warm Hank’s Balanced Salt Solutions
(HBSS) to remove excess probe in the medium and fluorescence was detected at
λex/λem= 491/516 nm.
Measurement of tissue persulfide. Tissue persulfide levels were estimated using a
fluorescent probe, SSip1 DA. SSip1 DA detects sulfane sulfur which is a sulfur atom
with six valence electrons and no charge (S0) and a component of persulfide64.
Briefly, tissues were harvested after perfusion with ice-cold PBS and frozen in
liquid nitrogen instantly. Tissues were homogenized in PBS with SSip-1 DA at
5 µM and centrifuged after incubation at room temperature in dark for 20 min.
Fluorescent of supernatant was measured using a microplate reader at λex/λem=
491 nm/525 nm. Fluorescent intensity was normalized by tissue weight.
Measurement of NADH/NAD+. NADH/NAD+ ratio in brain tissues or cultured
cells was measured by using a NAD/NADH quantitation colorimetric kit (K337-
100, BioVision, Inc.). Brain tissues were homogenized in extraction buffer and
centrifuged. We measured NADH/NAD+ ratio in the collected supernatant in
accordance with the manufacturer’s protocol. Cultured cells seeded in a 6-well plate
were washed twice with warm HBSS, scraped with a cell lifter, transferred to a new
tube, and homogenized. After centrifugation, the supernatant was used to measure
NADH/NAD+ ratio.
Measurement of Lactate. We measured lactate levels in brain tissue or cell culture
medium using a colorimetric assay kit (Eton Biosciences, 1200012002). Briefly,
~25 mg of tissue was homogenized in 400 µL ethanol (Sigma-Aldrich, 187380) and
centrifuged at 15,000 × g for 10 min at 4 °C. We then measured lactate in the
supernatant according to the manufacturer’s protocol. Tissue lactate levels were
normalized to protein content, measured by BCA assay. Lactate levels in the cell
culture medium were assayed directly using the same assay kit.
qPCR. Total RNA was extracted from brain tissues of mice using TRIzol reagent
(ThermoFisher Scientific). Briefly, a cerebral hemisphere was homogenized (Fisher
Scientific, Power Gen 125) in 1 mL TRIzol. After adding 200 µL of chloroform, the
sample was vortexed, incubated at RT for 3 min, then centrifuged at 12,000 × g at
4 °C for 10 min. The top layer was carefully transferred to a new tube. After adding
500 µL isopropanol, RNA was collected by centrifugation and washed with 75%
ethanol. cDNA was synthesized using MMLV-RT (Promega). SQOR, TST, ETHE1,
SUOX, CBS, CSE, 3MST, VEGF, HO-1, EPO, GLUT-1, COX1, NDUFV1, and 18S
ribosomal RNA transcript levels were measured by real-time PCR using a Realplex
2 system (Eppendorf North America). Primer sequences are listed in Supple-
mentary Table 7. Changes in the relative gene expression normalized to levels of
18S rRNA were determined using the relative CT method.
Immunoblots. Protein levels in forebrain tissues of rats, 13LGS, and mice were
determined by standard immunoblot techniques using primary antibodies against
GAPDH (1:5000, Cell Signaling, 5174), vinculin (1:2000, Cell Signaling, 4650),
SQOR (1:1000, Proteintech, 17256-1-AP), TST (1:1000, GeneTex, GTX114858),
ETHE1 (1:1000, GeneTex, GTX115707), SUOX (1:2000, Abnova, H00006821-
D01), CBS (1:5000, Cell Signaling, 14782), CSE (1:1000, Proteintech, 12217-1-AP),
3MST (1:1000, Sigma-Aldrich, HPA001240), VEGF (1:1000, Thermo Scientific,
710151), GLUT-1 (1:1000, Abcam, ab115730). Bound antibody was detected with a
horseradish peroxidase-linked antibody directed against rabbit IgG (1:10,000, Cell
Signaling, 7074), and was visualized using chemiluminescence with Lumigen ECL
Ultra kit (Lumigen, TMA-6).
Measurement of oxygen consumption rate. Oxygen consumption rate (OCR)
was measured using an Extracellular Flux Analyzer (Seahorse Biosciences, Seahorse
XFp Analyzer). Mitochondria were isolated from brains of mice or cerebral cortex
of rats and 13LGS as reported previously65. Mitochondrial isolation buffer (MSHE
+ BSA) was composed of 70 mM sucrose, 210 mM mannitol, 5 mM HEPES, 1 mM
EGTA and 0.5% (w/v) fatty acid-free BSA (pH 7.2). Mitochondrial assay solution
(MAS) was composed of 5 mM sodium pyruvate/sodium malate for mice (10 mM
sodium succinate for rats and 13LGS instead), 70 mM sucrose, 220 mM mannitol,
5 mM KH2PO4, 5 mM MgCl2, 2 mM HEPES, 1 mM EGTA and 0.2% (w/v) fatty
acid-free BSA, pH 7.2 at 37 °C. Cortex was minced with a razor blade, pestled 20
times with a plastic tissue grinder (Fisher Scientific, 14-222-358) in 600 µL of
MSHE+ BSA, then centrifuged at 800 × g at 4 °C for 10 min to collect the super-
natant. An aliquot of the supernatant was reserved for determination of protein
concentration by BCA assay; this aliquot was centrifuged at 8000 × g at 4 °C for
10 min and then the mitochondrial pellet was dissolved in MSA without BSA for
analysis. The remaining supernatant was also centrifuged at 8000 × g at 4 °C for
10 min but the mitochondrial precipitate was dissolved in MAS+ BSA. Mito-
chondria were diluted in this solution, then seeded into a XFp cell culture miniplate
(Seahorse Biosciences, Seahorse XFp FluxPak) at 2.5 or 5 µg/well. The plate was
centrifuged at 2000 × g at 4 °C for 15 min, then incubated 10 min at 37 °C. A
seahorse cartridge with detection probes (Seahorse Biosciences, Seahorse XFp
FluxPak) was loaded with adenosine 5′-diphosphate (ADP, final 5 mM for mice,
2.5 mM for rats, and 13LGS), oligomycine (final 2 µM for all animals), carbonyl
cyanide-p-trifluoromethoxyphenylhydrazone (FCCP, final 3 µM for mice, 4 µM for
rats, and 13LGS), and antimycin A (final 4 µM for mice, 3 µM for rats, and 13LGS)
in injection port A, B, C, and D, respectively. For rats and 13LGS, rotenone at 2 µM
was added to wells before adding Na2S. Mitochondrial OCR was measured
immediately after Na2S or vehicle (MAS+ BSA) into wells containing
mitochondria.
Measurement of NADH, membrane potential, and oxygen consumption in
mitochondria. Briefly, mice were euthanized, reperfused with ice-cold PBS, and
brains were harvested. Mitochondria were isolated from the brain as reported
previously66. ADP- and Na2S-induced changes in NADH, mitochondrial mem-
brane potential, and oxygen consumption rate were measured using a custom-
made spectrophotometer as previously described38.
Intracellular H2S levels and cell viability. Primary cortical neurons were pre-
pared from the cortex of embryonic day E15 mice derived from SQORΔN/+ parents
as described previously67. After seeding cells of each embryo into a 96-well plate,
genotypes of the embryo were determined. Cells were used for experiments on
11 days after seeding. To measure intracellular H2S levels, cells were incubated with
a fluorescent probe HSip-1 DA (Dojindo Molecular Technologies, Inc.) at 5 μM in
HBSS with 0.1% DMSO, washed with HBSS, subjected to OGD for 20 min, and
analyzed by a microplate reader at the wavelength of λex/λem= 491/516 nm as
described previously69. Cell viability after OGD for 1.5 h followed by reoxygenation
for 20 h was evaluated by crystal violet assay as reported previously67.
AAV-mediated gene transfer to the brain. To investigate the role of SQOR in
tolerance of female mice to hypoxia, we examined whether SQOR knockdown in
the brain makes female mice hypoxia-sensitive. We designed a recombinant AAV9
vector encoding eGFP and an shRNA targeting mouse Sqor driven by the U6
promoter. AAV9-CMV-eGFP-U6-mSQOR-shRNA (AAV-shSQOR) was admi-
nistered at 1010 viral particles per hemisphere via ICV injection to newborn female
CD-1 mice on postnatal day 0 (P0), as described previously39. AAV9-CMV/CAG-
eGFP (AAV-Ctrl) was injected into control female mice at the same viral particle
number. Mice were used for the experiment 7–9 weeks after AAV injection.
To determine the impact of increased neuronal levels of SQOR on resistance to
hypoxia and global cerebral I/R injury in vivo, we overexpressed SQOR in neurons
using AAV-mediated gene transfer in mice. We administered AAV9-hSYN1-
mSQOR-hSYN1-eGFP (AAV-SQOR) or AAV9-hSYN1-eGFP (AAV-GFP) at 1010
viral particles per hemisphere via intracerebroventricular (ICV) injection into the
brain of newborn male CD-1 mice. We used the human synapsin 1 (hSYN1)
promoter to drive neuron-specific expression of SQOR and GFP39.
We confirmed successful gene transfer into the brain by immunofluorescence
method against GFP using frozen coronal brain sections with the thickness of
12 µm as reported previously with some modification. We used chicken polyclonal
anti-GFP antibody (AvesLabs, GFP-1010, 1:1000) and Alexa Fluor® 488 conjugated
anti-chicken IgY antibody (Life Technologies, 1:300) as a primary and the second
antibody39. Fluorescence images were obtained using epifluorescent microscopy
with a Nikon Eclipse 80i microscope (Nikon Instruments).
GC-MS-based measurements of brain metabolites. Approximately 25 mg of
brain tissues were homogenized in 300 µL of ice-cold methanol (Sigma-Aldrich,
Fluka 14262) and 150 µL of H2O in a round-bottom Eppendorf tube (Fisher Sci-
entific, Power Gen 125). Next, 200 µL of ice-cold chloroform (Sigma-Aldrich,
650498) was added, the tube was vortexed, then the sample was shaken by a rotator
(Labnet, Revolver™ Tube Mixer) at 4 °C for 20 min and centrifuged at 15,000 × g for
10 min at 4 °C. The upper layer of the supernatant was transferred to a poly-
propylene tube. For selected experiments, the extraction water contained 2 mg/mL
norvaline (Nor, Sigma-Aldrich, St. Louis, MO, USA) as an internal standard for
normalization. For gas chromatography-mass spectrometry (GC-MS) analyses,
dried metabolites were derivatized in 2% methoxyamine hydrochloride in pyridine
(MOX, Sigma) followed by N-methyl-N-(tert-butyldimethylsilyl) tri-
fluoroacetamide + 1% tert-butyldimethylchlorosilane (TBDMS, Sigma) according
to published methods68. One microliter of the derivatized sample was injected into
an Agilent 7890B GC with a 30 m DB-35MS capillary column in line with an
Agilent 5977 T MS. A splitless inlet liner and inlet temperature of 270 °C were used
with a helium carrier gas flow rate of 1 mL/min. Electron impact ionization energy
was 70 eV, ion source temperature was 120 °C, and quadrupole temperature was
150 °C. Ion detection was performed in Scan Mode (m/z between 100 and 605). For
analysis of tissue metabolites, ion counts were normalized to the total ion counts of
the tissue sample.
MS-based measurements of sulfide metabolites
Derivatization of samples by monobromobimane (MBB). Tissues were homogenized
in Tris-HCl buffer (100 mM Tris-HCl, pH 9.5, 0.1 mM DTPA). Thirty µL of the
sample was incubated with 100 µL of Tris-HCl reaction buffer (100 mM Tris,
0.1 mM DTPA, pH 9.5) and 50 µL of MBB (10 mM, dissolved in acetonitrile) under
hypoxia (25 °C,1% O2) for 30 min, and the reaction was stopped by addition of
50 µL sulfosalicylic acid (200 mM).
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RP-HPLC analysis of hydrogen sulfide. Levels of hydrogen sulfide and thiosulfate in
brain tissues were measured by RP-HPLC as stable products sulfide-dibimane
(SDB) and thiosulfate bimane (TSB), respectively, as previously described70. The
separation of SDB and TSB was performed using Shimadzu Prominence 20 A
equipment with RF-10AXL (λex 390 mm and λem 475 mm) and an Eclipse XDB-
C18 column (4.6 × 250 mm, 5 µm) with gradient elution by 0.1% (v/v) tri-
fluoroacetic acid in acetonitrile. Typical retention times of SDB and TSB were
around 16.5 and 9.5 min, respectively. Free sulfide and thiosulfate levels were
calculated according to their standard curves.
Cysteine, homocysteine, and glutathione levels were measured by multiple
reaction monitoring (MRM) using Acquity UPLC system coupled to XEVO TQ
(Thermo Scientific) with electrospray ionization (ESI(+)). UPLC separation was
performed on a BEH C18 column (2.1 mm × 100 mm, 1.7 μm particle size)
(Waters, Mississauga, ON, Canada). Mobile phases for LC were water (0.1% TFA,
A) and acetonitrile (0.1% TFA, B), and the flow rate was set to 0.3 mL/min.
Gradient was as follows: 0 min, 15% B; 0–10 min, 45% B (linear); 10–11 min, 95% B
(linear) and hold for 1.0 min; 12–13 min, 15% B (linear) and hold for 2.0 min. Data
were collected in MRM mode by screening parent and daughter ions
simultaneously, cone voltage was set depending upon each specific MRM for each
metabolite, and the dwell time was automatically set by the MassLynxTM
4.1 software. The optimum collision energy and precursor/production ions for thiol
derivatives were summarized in Supplementary Table 8. Fold changes of cysteine,
homoCys, and glutathione levels were performed using the peak area ratios of
signature productions to corresponding stable S34DB (internal standards).
Enzyme activities of SQOR. SQOR activity in the brain was measured as reported
previously with some modification71. Approximately 50 mg of forebrain from rats,
13LGS, or a whole forebrain hemisphere of mice were homogenized in 400 µL in
RIPA lysis buffer (Boston BioProducts, BP-115). After centrifugation, the protein
concentration of the supernatant was adjusted to 10 mg/mL with RIPA buffer, then
adjusted to 0.5 mg/mL with PBS (pH 7.4) containing 22.2 µM coenzyme Q1
(Sigma-Aldrich, C9538). Na2S was quickly dissolved (final concentration 800 µM)
in 0.2 M Tris-HCl buffer (2.4 mM sodium sulfite, 0.1 mM DTPA, pH 9.5) deox-
ygenated with nitrogen bubble. Diluted supernatant (900 µL) was combined with
100 µL Na2S solution in a trUView Cuvette (Bio-Rad, 170-2511), immediately prior
to the start of the kinetic assay. We calculated SQOR activity as absorbance change
over 30 s at 275 nm (Bio-Rad, SmartSpec Plus).
Design of AAV-shRNA for SQOR knockdown in 13LG squirrels. To examine the
role of SQOR (SQOR) in 13LG squirrels, we performed brain SQOR knockdown
employing the shRNA technique combined with AAV infection. First, we validated
a species-specific target sequence for SQOR knockdown using primary myoblasts
isolated from 13LG squirrels. Primary myoblasts of 13LG squirrels were isolated
and stored in a cryogenic tank in the same manner as reported in mice
previously72. Primary myoblasts were seeded in collagen-coated 6-well plates and
transfected with shRNA when cells reached 40–60% confluence in F-10 medium
supplemented with 20% FBS and penicillin/streptomycin. We designed and syn-
thesized four shRNA plasmids (A, B, C, and D) with target sequences shown in
Supplementary Table 3 using a BLOCK-iT™ U6 RNAi Entry Vector Kit (Life
Technologies, catalog # K494500) and examined their knockdown efficiency.
shRNA transfection was performed using OptiMEM (Life Technologies, catalog #
31985-070) and lipofectamine 2000 (Life Technologies, catalog # 11668019)
according to the manufacturer’s protocol and cells were harvested at 48 h after
transfection. SQOR protein levels after transfection were determined using
immunoblotting (Supplementary Fig. 7e). We synthesized an AAV for in vivo
SQOR knockdown (AAV-shSQOR13LGS) based on the sequence of shRNA C,
which provided the highest degree of ex vivo knockdown in myoblasts. To
determine the most effective AAV serotype for use in the 13LGS brain, we com-
pared the gene transfer efficiency for four AAV serotypes (AAV2, 4, 8, and 9) using
an Adeno-associated virus Serotype Testing Kit with eGFP expression as a tag
protein (GeneCopoeia, catalog # AA320) to determine the most effective AAV to
transfer genes into brains of 13LGS. Brains of 13LGS were harvested one week after
AAV injection ICV (procedure is described below) and analyzed for eGFP
expression by qPCR with a primer set (GeneCopoeia, catalog # SCQP00002). Based
on the brain expression levels of eGFP, we chose AAV9 as a carrier virus of shRNA
for SQOR knockdown (Supplementary Fig. 7f).
Brain SQOR knockdown in 13LG squirrels. Weanling, non-reproductive 13LG
squirrels (body weight: 192–312 g, both sexes) were anesthetized with isoflurane in
an induction chamber (5% isoflurane) and fixed on a stereotaxic frame with ear
bars (ASI instruments, catalog # MM-8000/3). Anesthesia was maintained with
1–3% isoflurane using an anesthesia mask for rats (ASI instruments, catalog # RA-
100G). Fur was removed from the top of the head and the skin was prepped for
incision with standard aseptic technique. After application of local analgesia to the
skin site, the skull was exposed via a 2 cm incision, then bilateral burr holes were
made in the skull at the coordinate of A/P=+7.0 mm from the interaural line,
M/L= ±2.0 mm using a micro-drill (Braintree Scientific, catalog # MD-1200).
Coordinates were based on the 13LG squirrel brain atlas73. The needle of a
microsyringe (Hamilton, catalog # 80530) was inserted to a depth of D/V=+13.5
mm from the interaural line and, then, AAV-shSQOR13LGS or AAV-Ctrl (2.5 ×
1011 GC/hemisphere) in 12.5 µL of saline was slowly injected. After bilateral
injection and removal of the needle, holes of the skull were covered with a bone
wax and the skin incision was sutured closed. Animals were returned to their home
cage and used for hypoxia experiments two weeks later.
Bilateral common carotid artery occlusion (2 vessel occlusion, 2VO). To
investigate the role of SQOR in cerebral ischemia and reperfusion injury, CD-1
mice with or without AAV9-mediated SQOR expression were subjected to global
cerebral ischemia and reperfusion injury induced by 2VO in accordance with a
previous report with some modifications74. Briefly, mice (male, 7–8 weeks old)
were anesthetized by ketamine (80 mg/kg)/xylazine (12 mg/kg) IP, endotracheally
intubated with a 20-G i.v. catheter, and breathed air during the procedure. Bilateral
common carotid arteries were occluded with microclips (Fine Science Tools Inc.,
18055-04) for 12 or 20 min and reperfused by removing microclips. Rectal tem-
perature was monitored using a thermistor with a flexible wire (Physitemp
Instruments, Inc., IT-18) and maintained at 37.5 °C using a heating pad (FHC, Inc.,
DC Temperature Control System) until 15 min after the start of reperfusion. Sham-
operated mice were subjected to the same procedures except for occlusion of
common carotid arteries. Mice were given 1 mL of lactated Ringer solution con-
taining 5% dextrose IP after surgery daily. Neurofunctional impairment was
assessed and scored as previously reported75. Survival rate for 3 days after surgery
of control mice and mice overexpressing SQOR were 50% (6/12) and 100% (9/9),
respectively. The investigator (EM) who performed 2VO operation and neuro-
functional impairment assessment was blinded to the identity of the mice.
Histological analysis after 2VO. Mice were anesthetized with pentobarbital
(200 mg/kg, IP), perfused with 4% paraformaldehyde (PFA) in ice-cold phosphate-
buffered saline (PBS), and the whole brain was harvested 3 days following 20 min
2VO. Brains were further fixed in 4% PFA in 15 mL conical tubes until brains settle
on the bottom. After dehydration with ethanol, 8 µm coronal brain sections were
cut with a rotary microtome (Leica Biosystems, Inc.). Sections were stained with
hematoxylin and eosin and microphotographs were taken using a microscope. The
number of viable neurons in hippocampal CA1/CA3 regions and cerebral cortex
were manually counted. For each brain region, 4–6 randomly selected levels were
analyzed by an investigator who was blinded to treatment.
Fluoro-Jade B staining after 2VO. To evaluate neuronal degeneration in cerebral
cortex and hippocampus at 72 h after 20 min of 2VO in male mice transfected with
AAV-GFP or AAV-SQOR, paraffin-embedded coronal brain sections were stained
with Fluoro-Jade B according to the previously described procedure76. Fluoro-Jade
B is a fluorochrome used for labeling degenerating neurons. Paraffin sections were
cut at a thickness of 8 μm. Six randomly selected brain sections per mouse were
stained with Fluoro-Jade B. Briefly, deparaffinized, and rehydrated brain sections
were incubated in 0.06% potassium permanganate solution for 10 min. After rin-
sing, sections were incubated in 0.0004% of Fluoro-Jade B staining solution for
20 min. Following Fluoro-Jade B staining, slides were rinsed, air dried, and cov-
erslipped. Thereafter, 3 brain regions (cerebral cortex, CA1, and CA3) in each brain
section were analyzed by epifluorescent microscopy with a Nikon Eclipse 80i
microscope (Nikon Instruments). Fluorescein isothiocyanate (FITC) filter system
was used to visualize Fluoro-Jade B labeling. One image per region per brain
section was captured, and thus total of 6 images per region per mouse was ana-
lyzed. The number of Fluoro-Jade B positive cells per 1 mm2 in each region was
calculated with ImageJ 1.49v (NIH) using the plug-in Cell Counter in a blinded
manner.
Cell culture and transfection studies in SH-SY5Y. We cultured human neuro-
blastoma cell line SH-SY5Y in DMEM/F12 50/50 Mix (Cellgro by Mediatech, Inc.)
supplemented with 10% fetal bovine serum (FBS), 100 IU/mL penicillin, and 100
μg/mL streptomycin at 37 °C in air with 5% CO2. For SQOR expression, SH-SH5Y
cells were seeded in 96-well, 6-well or 10 cm diameter plates, and cultured for
24–48 h until 30–50% confluent. We transfected the cells with plasmid DNA for
mock (Invitrogen, 12536017) or SQOR expression (Harvard Medical School,
HsCD00043463) at 0.2, 4, or 16 μg/well using OptiMEM (Invitrogen, 31985-062)
containing Lipofectamine 2000 reagent (Invitrogen, 11668) at 0.2, 4, or 16 μL/well.
Cells were used for experiments 48 h after transfection.
For SQOR silencing, SH-SY5Y cells were seeded in 6-well plates, transfected
with 20 nM control or SQOR knockdown siRNA (Dharmacon Inc., D-001810-10-
20 or L-008271-01-0010, respectively) using OptiMEM with Lipofectamine
RNAiMAX reagent (Invitrogen, 13778075), and used for assays after 48 h. We
included a glycolysis inhibitor (10 mM 2-deoxy-D-glucose) in the cell culture
medium during hypoxia in some assays to attenuate the influence of high glycolytic
activity in these cells.
Intracellular persulfide measurement. Intracellular persulfide levels in SH-SY5Y
cells were measured using a sulfane sulfur-specific probe, SSP4 (provided by Dr.
Ming Xian, also available at Dojindo Molecular Technologies, Inc.) as reported
previously77. Briefly, after cells get 30–50% confluent in a 96-well plate, cells were
subjected to transfection with plasmids for SQOR expression or mock transfection.
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Cells were incubated with SSP4 at 10 μM (0.1%DMSO) at 37 °C for 20 min, washed
with HBSS and measured fluorescent intensity at λex= 482 nm, λem= 515 nm
using a microplate reader.
Hypoxia and oxygen/glucose deprivation. For in vitro hypoxia experiments, SH-
SY5Y cells were incubated for 3 h in DMEM 37 °C either in air (control) or 1% O2
(hypoxia) in an air-tight chamber (Billups-Rothenberg, Modular Incubation
Chamber), both with 5% CO2. For oxygen-glucose deprivation (OGD), SH-SY5Y
cells were incubated for 3 h at 37 °C in RPMI1640 (Cellgro, 10-043-CV) in the air
or 1% O2, both with 5% CO2.
Relative mtDNA level. The mtDNA copy number on the brain and heart was
determined by qPCR analysis. Amplification curves for the COX I gene of the
mtDNA and the NDUFV1 nuclear DNA gene were obtained to measure the
relative mtDNA/nuclear DNA ratio. The reaction was initiated at 94 °C for 10 min,
followed by 40 cycles through 94 °C × 10 s, 60 °C × 30 s, and 94 °C × 10 s. All
reactions were run in duplicate78,79.
Hemoglobin and hematocrit. Immediately after the mice were anesthetized, their
blood will be aspirated from the heart with a heparin syringe, hemoglobin, and
hematocrit were measured using a blood gas analyzer (ABL 800 FLEX; Radiometer
Medical, Bronshoj, Denmark).
Measurement of oxygen dissociation curve (ODC). Oxygen dissociation curves
were determined with a Hemox-Analyzer (TCS Scientific Corp., New Hope,
PA)80. Collected whole blood (20 µL) was diluted with HEMOX solution (3 mL,
TCS Scientific Corporation, New Hope, PA) and the anti-foaming agent (6 µL, TCS
Scientific Corporation). HEMOX solution contains N-[Tris(hydroxymethyl)
methyl]-2-aminoethanesulfonic acid (TES, 30 mM), sodium chloride (135 mM),
and potassium chloride (5 mM) in water (pH 7.4). The ODC of the diluted blood
sample was measured using a HEMOX analyzer (TCS Scientific Corporation) with
the sample maintained at 37 °C. The partial pressure of oxygen at which 50% of Hb
is oxygenated was determined as P50 from ODC.
Ovariectomy and 17β-estradiol replacement. WT CD-1 female mice (10-
14 weeks old) were subjected to ovariectomy or sham operation as reported
previously.81 A silicon capsule filled with sesame oil with or without 17β-estradiol
(Sigma-Aldrich, E8875) at 36 µg/mL was implanted subcutaneously on the back of
mice. Mice were used for experiments after 2 weeks.
Enzyme activities of sulfide-producing enzymes. Enzyme activity of cystathio-
nine beta synthase (CBS), cystathionine gamma lyase (CSE), and 3-
mercaptopyruvate sulfurtransferase (3MST) in the brains of rats and 13LGS were
measured by monitoring H2S production from brain lysates in the presence and
absence of chemical inhibitor of each enzyme. Approximately 25 mg of the brain
was homogenized in 400 µL of 30 mM HEPES buffer (1 mM EDTA, pH 7.4) and
centrifuged at 15,000 × g at 4 °C for 10 min. Supernatant was transferred to a new
tube and diluted with HEPES buffer to adjust protein concentration to 1 mg/mL.
The reaction cocktails were based in HEPES buffer and contained substrates and
cofactors specific to each enzyme reaction and a H2S-specific fluorescent probe
(20 µM HSip-1) were prepared with or without an inhibitor for each enzyme. The
reaction cocktails included: for CBS, 20 mM homocysteine, cysteine 20 mM, 0.1
mM pyridoxal-phosphate, 0.2 mM S-adenosyl-L-methionine; for CSE: 20 mM
cysteine, 0.1 mM pyridoxal-phosphate; and for 3MST: 0.2 mM 3-mercaptopyr-
uvate, 0.2 mM dithiolethione. Inhibitors were: 2 mM aminooxyacetic acid (AOAA)
for CBS; 2 mM D,L-propargylglycine (PAG) for CSE; and 0.2 mM compound 3 for
3MST82. Immediately after mixing 50 µL of HEPES reaction buffer and 50 µL of
supernatant in a 96-well plate, we monitored fluorescence at λex/λem= 491/516 nm
over 30 min, then calculated relative enzyme activity using fluorescence of the
reaction with inhibitor minus fluorescence without inhibitor for each enzyme.
Measurements of ATP. ATP levels in mitochondria isolated from SH-SY5Y cells
were measured using a Luminescent ATP Detection Assay Kit, using the manu-
facturer’s protocol (Abcam, ab113849). Mitochondria were isolated using a mito-
chondria isolation kit (ThermoFisher Scientific, 89874), then seeded in a 96-well
plate at 2 µg/well. Mitochondria were then incubated with 1 µM sodium sulfide
(Na2S, Sigma-Aldrich, 208043) or vehicle (PBS) at 37 °C for 5 min in the presence
of 10 mM sodium succinate, 5 mM adenosine 5′-diphosphate and 4 µM rotenone in
MAS+ BSA buffer (described in a method section for the Seahorse apparatus), and
lysed by adding detergent. For hypoxia exposure, ATP was measured in SH-SY5Y
cells transfected with plasmids for 48 h, then exposed to 21 or 1% O2 for 3 h in the
presence of 10 mM 2-deoxyglucose in DMEM.
Measurements of complex IV activity. Complex IV activity of SH-SY5Y cells
were measured using a Complex IV Human Enzyme Activity Microplate Assay Kit
(Abcam, ab109909). We measured complex IV activity in SH-SY5Y cells seeded into
a 10 cm diameter dish, transfected with plasmids for mock or SQOR expression
over 48 h, then exposed to 1% or 21% O2 for 3 h. Procedures were in accordance
with the manufacturer’s protocol, and in a dark room to prevent signal loss.
Permanent middle cerebral artery occlusion (pMCAO). WT CD-1 mice (male,
8–10 weeks old) were subjected to permanent MCAO as reported previously with
some modifications83. Briefly, mice were anesthetized with 1.5% isoflurane in
oxygen. Mice breathed 100% oxygen with spontaneous breathing from the
induction of anesthesia to 15 min after MCA reperfusion. A 7-0 monofilament
(Doccol Corp., catalog # 702156PK5Re) was inserted via an internal carotid artery
to occlude the middle cerebral artery (MCA). Saline or OHCb at 250 µmol/kg was
administered IV at 10 min before the onset of MCAO. Rectal temperature was
monitored and kept at 37 ± 0.5 °C using a heating pad under mice during surgery
until mice recover from anesthesia. Changes in cerebral blood flow (CBF) were
monitored during surgery to confirm the occlusion of MCA using a laser Doppler
flowmetry (Moor Instruments, Inc.) probe positioned at 2 mm posterior, 5 mm
lateral from the Bregma. All mice used in this study exhibited the reduction of CBF
over 80% from the baseline after MCA occlusion. Taking circadian rhythm into
account, all mice were subjected to surgery in the daytime (9:00 to 17:00). Mice
received 1 mL of 5% dextrose-enriched lactated Ringer’s solution (ip) daily to avoid
dehydration. After evaluating neurological function according to the previously
reported criteria84, brains were harvested to measure cerebral infarct volume using
triphenyltetrazolium chloride (TTC) staining at 24 h after onset of MCAO.
Transient middle cerebral artery occlusion (tMCAO). WT CD-1 mice (male,
8–10 weeks old) were subjected to transient MCAO for 60 min and reperfusion for
48 h according to a previous report with some modification85. Briefly, mice were
anesthetized with 1.5% isoflurane in oxygen. Mice breathed 100% oxygen with
spontaneous breathing from the induction of anesthesia to 15 min after MCA
reperfusion. Rectal temperature was monitored and kept at 37 ± 0.5 °C using a
heating pad under mice during surgery until mice recover from anesthesia.
Changes in cerebral blood flow (CBF) were monitored during surgery to confirm
the occlusion of MCA using a laser Doppler flowmetry (Moor Instruments, Inc.)
probe positioned at 2 mm posterior, 5 mm lateral from the Bregma. Common
carotid artery (CCA) was occluded with a microclip and a 7-0 monofilament was
inserted via the isolated external carotid artery (ECA) through an internal carotid
artery to occlude MCA. MCA was reperfused by removing a monofilament at 60
min after starting MCAO. CCA was reperfused after ECA closure by removing a
microclip at 15 min after MCA reperfusion. Saline or SS20 at 250 µmol/kg was
administered IV at 15 min before MCA reperfusion. Taking circadian rhythm into
account, all mice were subjected to surgery in the daytime (9:00 to 17:00). Mice
received 1 mL of 5% dextrose-enriched lactated Ringer’s solution (ip) daily to avoid
dehydration. After evaluating neurological functional score84, brains were har-
vested to measure cerebral infarct volume using TTC staining at 48 h after MCAO.
Statistics. Data for continuous variables are presented as means with plots of all
individual values. An unpaired two-tailed Student’s t-test or Mann–Whitney U test
was used to compare two independent groups, as appropriate, for continuous
variables. One-way or two-way analysis of variance (ANOVA) followed by Sidak’s
correction for post-hoc comparisons and Kruskal–Wallis test followed by Dunn’s
multiple comparisons were used for post-hoc comparisons for normally distributed
data and non-normally distributed data, respectively. In three group comparisons,
post-hoc comparisons were performed only in comparisons between two groups of
each set. Survival rates were estimated using the Kaplan–Meier method and a log-
rank test were used to compare the survival curves between groups. Significance
was considered at the level of P < 0.05. GraphPad Prism 8.4.3 (GraphPad Software
Inc., La Jolla, CA, USA) was used for statistical analyses.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
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